Alkaline Water 10-K 23 Oct 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Oct. 22, 2014	Jun. 30, 2013
Document and Entity Information:	'	'	'
Entity Registrant Name	'PureSafe Water Systems, Inc.	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Entity Central Index Key	'0000764839	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	1,414,187,330	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Public Float	'	'	$14,590,381

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$2,199	$63,571
Inventories	141,636	322,718
Prepaid expenses and other current assets	35,437	54,478
Total Current Assets	179,272	440,767
Property and equipment, net of accumulated depreciation of $179,290 and $164,710, respectively	0	49,014
Patents and trademarks, net of accumulated amortization of $47,919 and $41,816, respectively	59,422	58,068
Other assets	33,500	28,451
Total Assets	272,194	576,300
Current Liabilities:	'	'
Accounts payable and accrued expenses	1,209,319	695,589
Accrued compensation	1,267,382	972,286
Deferred rent payable	0	7,050
Accrued consulting and director fees	144,000	144,000
Customer deposits	0	149,588
Notes payable to officer and director (including accrued interest of $193,703 and $138,132, respectively)	827,254	811,132
Convertible promissory note (including accrued interest of $154,528 and $141,564 and net of debt discount of $210,781 and $80,606, respectively)	1,238,838	1,111,110
Promissory notes payable (including accrued interest of $240,807 and $220,295 respectively)	593,153	706,829
Fair value of detachable warrants and conversion option	299,000	263,300
Accrued dividends payable	190,328	190,328
Common stock to be issued	38,423	0
Total Current Liabilities	5,807,697	5,051,212
Long-Term Liabilities:	'	'
Promissory notes payable, net of current portion	0	8,196
Total Long-Term Liabilities	0	8,196
Total Liabilities	5,807,697	5,059,408
Commitments and Contingencies	'	'
Stockholders' Deficiency:	'	'
Preferred stock par value $0.001 par value; 10,000,000 shares authorized; 184,144 and 184,195 shares issued and outstanding (liquidation preference $3,025,450 and $2,917,150, as of December 31, 2013 and 2012, respectively)	184	184
Common stock par value $0.001: 2,000,000,000 shares authorized; 934,171,800 shares issued and 934,167,400 shares outstanding at December 31, 2013; 561,343,935 shares issued and 561,339,535 shares outstanding at December 31, 2012	934,171	561,343
Additional paid in capital	41,804,413	40,423,615
Treasury stock, at cost, 4,400 shares of common stock	-5,768	-5,768
Subscriptions receivable - (including accrued interest of $0 and $93,825 respectively)	0	-431,025
Accumulated deficit	-48,268,503	-45,031,457
Total Stockholders' Deficiency	-5,535,503	-4,483,108
Total Liabilities and Stockholders' Deficiency	$272,194	$576,300

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets Parentheticals (USD $)	Dec. 31, 2013	Dec. 31, 2012
Parentheticals	'	'
Property and equipment, accumulated depreciation	$179,290	$164,710
Patents and trademarks accumulated amortization	47,919	41,816
Interest on note payable to officer and directors	193,703	138,132
Accrued interest on convertible promissory note	154,528	141,564
Convertible promissory note debt discount	210,781	80,606
Promissory notes payable, accrued interest	240,807	220,295
Preferred Stock, par value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued	184,144	184,195
Preferred Stock, shares outstanding	184,144	184,195
Preferred Stock, liquidation preferencee	$3,025,450	$2,917,150
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	2,000,000,000	2,000,000,000
Common Stock, shares issued	934,171,800	561,343,935
Common Stock, shares outstanding	934,167,400	561,339,535
Treasury Stock, shares	4,400	4,400

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues:	'	'
Sales	$0	$495,000
Cost of Sales	56,344	669,535
Gross Profit (Loss)	-56,344	-174,535
Operating expenses:	'	'
Compensation and related benefits, including stock-based compensation of $478,700 and $449,700 for the years ended December 31, 2013 and 2012, respectively	1,161,739	1,232,140
Insurance and medical benefits	82,553	83,557
Research and development	55,874	62,032
Professional, legal and consulting fees, including stock-based compensation of $257,000 and $4,500 for the years ended December 31, 2013 and 2012, respectively	394,209	212,145
Marketing, including stock-based compensation of $0 and $13,900 for the years ended December 31, 2013 and 2012, respectively	25,835	213,553
Occupancy	476,022	263,116
Loss on sale/abandonment of fixed assets	12,234	34,709
Other administrative and general	349,927	340,878
Total operating expenses	2,558,393	2,442,130
Loss from operations	-2,614,737	-2,616,665
Other income (expense):	'	'
Interest income	15,131	20,349
Other income	23,538	0
Interest expense, including interest to related parties of $55,571 and $70,720 for the years ended December 31, 2013 and 2012, respectively	-1,053,978	-1,161,569
Change in fair value of derivative liabilities	393,000	998,300
Total Other Income (Expense)	-622,309	-142,920
Net Loss	-3,237,046	-2,759,585
Dividend on preferred stock	-108,300	-108,300
Net Loss Attributable to Common Stockholders	($3,345,346)	($2,867,885)
Net Loss Attributable to Common Stockholders Per Share basic and diluted	$0	($0.01)
Weighted average number of shares outstanding	922,685,840	388,044,980

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations Parentheticals (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statements of Operations Parentheticals	'	'
Compensation and related benefits, stock-based compensation	$478,700	$449,700
Professional, legal and consulting fees, stock-based compensation	257,000	4,500
Marketing, including stock-based compensation	0	13,900
Interest expense, interest to related parties	$55,571	$70,720

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Deficiency (USD $)	Preferred Stock Shares	Preferred Stock Amount	Common Stock Shares	Common Stock Amount	Additional Paid-in Capital	Treasury Stock at Cost	Subscription Receivable	Accumulated deficit	Total Stockholder's Deficiency
		USD ($)		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Dec. 31, 2011	184,144	184	340,389,004	340,387	38,667,449	-5,768	-410,738	-42,271,872	-3,680,358
Sale of common stock for cash	0	0	51,227,383	51,227	361,043	0	0	0	412,270
Common stock issued for loan conversion	0	0	158,491,010	158,491	693,061	0	0	0	851,552
Common stock issued in connection with debt	0	0	4,375,000	4,375	170,625	0	0	0	175,000
Common stock issued for settlement of customer deposits (includes $37,500 of stock based compensation)	0	0	4,187,500	4,188	163,312	0	0	0	167,500
Issuance of Series B Preferred Stock	51	0	0	0	0	0	0	0	0
Common stock issued for services	0	0	2,674,038	2,675	165,225	0	0	0	167,900
Reclassification of derivative liability	'	$0	'	$0	($80,100)	$0	$0	$0	($80,100)
Warrants granted for services	'	0	'	0	283,000	0	0	0	283,000
Accrued interest	'	0	'	0	0	0	-20,287	0	-20,287
Net loss	'	0	'	0	0	0	0	-2,759,585	-2,759,585
Balance at Dec. 31, 2012	184,195	184	561,343,935	561,343	40,423,615	-5,768	-431,025	-45,031,457	-4,483,108
Sale of common stock for cash	0	0	106,066,743	106,067	464,733	0	0	0	570,800
Common stock issued for warrant exercise	0	0	11,609,661	11,610	52,904	0	0	0	64,514
Common stock issued for settlement of notes payable	0	0	23,021,012	23,021	102,442	0	0	0	125,463
Common stock issued for settlement of convertible debt	0	0	121,376,671	121,377	369,494	0	0	0	490,871
Common stock issued for services	0	0	74,509,222	74,509	182,491	0	0	0	257,000
Common stock issued for employee compensation	0	0	27,200,000	27,200	144,100	0	0	0	171,300
Common stock issued for penalty shares	0	0	9,044,556	9,044	32,890	0	0	0	41,934
Return of series B preferred stock for no consideration	-51	0	0	0	0	0	0	0	0
Reclassification of derivative liability	'	0	'	0	175,000	0	0	0	175,000
Warrants granted for services	'	0	'	0	302,900	0	0	0	302,900
Accrued interest	'	0	'	0	0	0	-15,131	0	-15,131
Write-off subscription receivable and accrued interest	'	0	'	0	-446,156	0	446,156	0	0
Net loss	'	$0	'	$0	$0	$0	$0	($3,237,046)	($3,237,046)
Balance at Dec. 31, 2013	184,144	184	934,171,800	934,171	41,804,413	-5,768	0	-48,268,503	-5,535,503

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows From Operating Activities:	'	'
Net Loss	($3,237,046)	($2,759,585)
Adjustments to reconcile net loss to net cash used in operating activities	'	'
Depreciation	14,580	52,997
Amortization of patents and trademarks	6,104	6,104
Net loss on sale/abandonment of fixed assets	12,234	34,707
Loss on abandonment of inventory	51,471	0
Interest expense - amortization of deferred financing	25,066	125,428
Interest expense - penalty interest	353,322	9,000
Interest expense - stock based compensation, derivative liabilities	4,500	0
Stock based compensation	731,200	505,600
Loss on conversion of convertible notes to notes payable	0	85,000
Deferred rent	-7,050	-25,750
Interest receivable	-15,131	-20,287
Accretion of debt discount	223,825	796,040
Interest expense - derivative liabilities	245,200	0
Change in fair value of warrants and embedded conversion option	-393,000	-998,300
Changes in assets and liabilities:	'	'
Prepaid expenses and other current assets	19,041	2,196
Inventories	129,611	145,375
Other assets	465	34,705
Customer deposits	-149,588	149,588
Accounts payable, accrued expenses, accrued interest, accrued dividends, accrued compensation, accrued consulting and director fees, and other current liabilities	948,165	882,779
Net Cash Used in Operating Activities	-1,037,031	-974,403
Cash Flows From Investing Activities:	'	'
Patent costs	-7,458	0
Proceeds from sale of property and equipment	22,200	0
Net Cash Provided by Investing Activities	14,742	0
Cash Flows From Financing Activities:	'	'
Cash proceeds from sale of common stock	570,800	412,270
Cash proceeds from exercise of warrants	64,514	0
Cash proceeds from the exercise of warrants, common stock to be issued	38,423	0
Proceeds from convertible promissory notes	376,500	768,500
Repayment of convertible notes payable	-32,500	0
Cash paid for loan costs	0	-130,024
Cash proceeds from officers and directors convertible loans	0	105,000
Cash proceeds from promissory notes, officers and directors	9,051	0
Repayment of officers and directors loans	-48,500	-104,000
Cash proceeds from notes payable	12,500	75,000
Repayment of notes payable	-29,871	-207,000
Net Cash Provided by Financing Activities	960,917	919,746
Net decrease in cash	-61,372	-54,657
Cash at beginning of year	63,571	118,228
Cash at end of the year	2,199	63,571
Supplemental disclosures of cash flow information:	'	'
Cash paid during the year for interest	29,717	28,837
Non-Cash Investing and Financing Activities:	'	'
Common stock issued for the settlement of liabilities	616,334	851,552
Common stock issued in connection with debt	0	175,000
Common stock issued for the settlement of a customer deposit	0	130,000
Reclassification of derivative liabilities to equity	175,000	0
Reclassification of equity instrument to derivative liabilities	0	-80,100
Conversion of convertible notes payable to notes payable	0	185,000
Debt discount recorded on convertible debt and warrants accounted for as derivative liabilities	354,000	0
Loan financing costs	22,000	0
Write-off subscription receivable and accrued interest	446,156	0
Conversion of notes payable to convertible notes payable	$0	$207,770

DESCRIPTION_OF_BUSINESS

DESCRIPTION OF BUSINESS	12 Months Ended
	Dec. 31, 2013
DESCRIPTION OF BUSINESS	'
DESCRIPTION OF BUSINESS	'
	NOTE 1 – DESCRIPTION OF BUSINESS
	PureSafe Water Systems, Inc. (the "Company") is a Delaware corporation engaged in the design, development, manufacturing and sales of the PureSafe ™ First Response Water System (the “FRWS” ), both within and outside of the United States. The Company's corporate headquarters are located in Plainview, New York.

BASIS_OF_PRESENTATION_AND_ACCO

BASIS OF PRESENTATION AND ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
BASIS OF PRESENTATION AND ACCOUNTING POLICIES	'
BASIS OF PRESENTATION AND ACCOUNTING POLICIES	'
	NOTE 2 – BASIS OF PRESENTATION AND ACCOUNTING POLICIES.
	Basis of Presentation
	The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
	Principles of Consolidation
	The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.
	The Company's consolidated subsidiaries and/or entities are as follows:
	Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation(date of acquisition, if applicable)	Attributable interest
	PureSafe Manufacturing and Research Corporation	Delaware	29-Sep-09	100%
	The consolidated financial statements include all accounts of the Company and consolidated subsidiaries and/or entities as of December 31, 2013 and 2012 and for the years then ended.
	All inter-company balances and transactions have been eliminated.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The most significant estimates, among other things, are used in accounting for allowances for deferred income taxes, expected realizable values for long-lived assets (primarily intangible assets and property and equipment), contingencies, as well as the recording and presentation of its common stock and other securities. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the consolidated financial statements in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2013 and 2012 the Company did not have any cash equivalents.
	Patents and Trademarks
	Patents and trademarks amortize ratably over nine to fourteen years. The Company assesses the carrying value of its patents for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the years ended December 31, 2013 and 2012.
	Property and Equipment
	Property and equipment consists primarily of equipment and furniture and fixtures and is stated at cost. Depreciation and amortization are provided using the straight line method over the estimated useful lives (generally three to seven years) of the related assets. Leasehold improvements, once placed in service, are amortized over the shorter of the useful life or the remainder of the lease term. Expenditures for maintenance and repairs, which do not extent the economic useful life of the related assets, are charged to operations are incurred. Gains or losses on disposal of property and equipment are reflected in the statement of operations in the period of disposal.
	Revenue Recognition
	The Company generally recognizes revenues under Staff Accounting Bulletin No. 104 when the following criteria are met, persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller's price to the buyer is fixed or determinable, and collectibility is reasonably assured. In addition the Company may enter into agreements that include multiple elements (i.e., products and services/training). Revenue under multiple element arrangements is recognized in accordance with FASB ASC 605-25 Multiple-Element Arrangements (“ASC 605”). When vendor specific objective evidence or third party evidence of selling price for deliverables in an arrangement cannot be determined, the Company develops a best estimate of the selling price to separate deliverables and allocates arrangement consideration using the relative selling price method. Additionally, this guidance eliminates the residual method of allocation. If an arrangement includes undelivered elements that are not essential to the functionality of the delivered elements, we defer the fair value of the undelivered elements with the residual revenue allocated to the delivered elements. Fair value is determined based upon the price charged when the element is sold separately. If there is not sufficient evidence of the fair value of the undelivered elements, no revenue is allocated to the delivered elements and the total consideration received is deferred until delivery of those elements for which objective and reliable evidence of the fair value is not available. For the years ended December 31, 2013 and 2012, the Company did not have any multiple deliverable elements.
	Inventories
	Inventory consisting primarily of finished goods and raw materials is stated at the lower of cost or market utilizing the first-in, first-out method. The Company continually analyzes its slow-moving, excess and obsolete inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves. If the Company does not meet its sales expectations, these reserves are increased. Products that are determined to be obsolete are written down to net realizable value. As of December 31, 2013, the inventory has been written down to its net realizable value.
	Deferred Financing Costs
	Cost incurred in conjunction with the debt financing has been capitalized and will be amortized to interest expense using the straight line method, which approximates the interest rate method over the term of the debt and is included as a component of other assets. Amortization of deferred financing cost was approximately $25,000 and $125,000 for the years ended December 31, 2013 and 2012, respectively.
	Derivative Liabilities
	In connection with the issuance of certain convertible promissory notes, the terms of the convertible notes included an embedded conversion feature; which provided for the settlement of certain convertible promissory notes into shares of common stock at a rate which was determined to be variable. The Company determined that the conversion feature was an embedded derivative instrument pursuant to ASC 815 “Derivatives and Hedging”
	The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible promissory notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.
	The fair value of conversion options that are convertible at a fixed number of shares or at a fixed conversion price are recorded using the intrinsic value method and conversion options at variable rates are valued using a Black-Scholes Valuation Model. Variable conversion options are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815. Since, “down-round protection” is not an input into the calculation of the fair value of the conversion option and cannot be considered “indexed to the Company’s own stock” which is a requirement for the scope exception as outlined under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Black-Scholes Valuation Model to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model. The Company’s outstanding warrants did not contain any down round protection.
	The Black-Scholes Valuation Model is used to estimate the fair value of the warrants and conversion option. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the instrument granted.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.10 - 1.75%	0.37 - 1.18%
	Expected life	3 - 5 years	1 month - 6 years
	Expected volatility	125% - 175%	108%-171%
	Dividends	0.00%	0.00%
	Stock-Based Compensation
	The Company reports stock-based compensation under Accounting Standard Codification (“ASC”) 718 “Compensation – Stock Compensation”. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.
	The Company accounts for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.
	For the years ended December 31, 2013 and 2012 the Company recorded stock based compensation of $731,200 and $505,600, respectively.
	The Black-Scholes option valuation model is used to estimate the fair values of options. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the subject options or warrants.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.3 - 1.6%	0.36%
	Expected life	3 to 5 years	3 years
	Expected volatility	125% - 175%	117%
	Dividends	0.00%	0%
	Fair Value of Financial Instruments
	The Company’s financial instruments consist principally of cash, accounts payable and accrued expenses and debt payable. The Company determines the estimated fair value of such financial instruments presented in these financial statements using available market information and appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate fair value due to their short term nature.
	Advertising and Marketing
	Advertising and marketing costs are expensed as incurred and are included in selling, general and administrative expenses. The Company incurred a charge of approximately $25,835 and $213,553 for the years ended December 31, 2013 and 2012, respectively.
	Income Taxes
	Income taxes are accounted for under ASC 740, "Income Taxes," which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and net operating loss and tax credit carryovers. Valuation allowances are established when necessary to reduce deferred tax assets to amounts more likely than not to be realized.
	Impairment of Long-Lived Assets
	The Company assesses the recoverability of its long lived assets, including property and equipment when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company first compares the carrying amount of the asset to the asset’s estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the asset’s estimated future cash flows (discounted and with interest charges). If the carrying amount exceeds the asset’s estimated futures cash flows (discounted and with interest charges), the loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets. Based on its assessments, the Company did not incur any impairment charges for the years ended December 31, 2013 and 2012.
	Research and Development
	Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge, which will be useful in developing new products or processes. The Company expenses all research and development costs as incurred. The Company incurred a charge of approximately $55,874 and $62,032 for the years ended December 31, 2013 and 2012, respectively.
Subsequent Events
The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would require adjustment or disclosure in the consolidated financial statements.

GOING_CONCERN

GOING CONCERN	12 Months Ended
	Dec. 31, 2013
GOING CONCERN	'
GOING CONCERN	'
	NOTE 3 – GOING CONCERN
	The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred a net loss of approximately $3,237,000 and $2,760,000 for each of the years ended December 31, 2013 and 2012 respectively. The Company has a working capital deficit of approximately $5.6 million and $4.6 million as of December 31, 2013 and 2012 respectively. The Company continues to incur recurring losses from operations and has an accumulated deficit since inception of approximately $48.3 million. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
	The Company’s continuation as a going concern is dependent upon its ability to bring the Company’s products to market and generate revenues, control costs, and obtain additional financing, as required and on reasonable terms. The Company’s plans with respect to these matters include restructuring its existing debt and raising additional financing through issuance of preferred stock, common stock and/or debt. On January 23, 2013, The Company signed an Engineering Package Agreement (“ETG Agreement”) with Engineering Technologies Group, Inc. (“ETG”), Hopkinton, Massachusetts. Under the engineering agreement, ETG will provide detailed electronic engineering drawings and purchase specifications for the Company’s water purification and filtration product and to facilitate the outsourcing of the assembly, sub-assembly and manufacturing. On January 25, 2013, the Company entered into an Exclusive Sales and Marketing Agreement (the “Distribution Agreement”) with Global Equipment Marketing, Inc. (“GEM”), Hopkinton, Massachusetts, a distribution and marketing company. Under the Distribution Agreement, on an exclusive basis, GEM is responsible for promoting and selling the Company’s products at their cost and expense. In exchange, GEM will receive a discount from the list prices of PureSafe products in connection with sales to its dealers, distributors, representatives and resellers. The Company remains responsible for the design and manufacturing of the products. The Company was evicted from its facilities at 160 Dupont Street, Plainview, NY 11803. The Company plans to outsource production of the product in the future. Any remaining inventory was moved to ETG’s facilities in Hopkinton, Mass. On April 2, 2014, The Company announced that Stephen Hicks and Gilbert Steedley were appointed to the Board of Directors and that Stephen Hicks was appointed President of the Company. Henry Sargent was appointed Vice President and Secretary.
	The Company’s goal is to generate the sales of the Company's flagship mobile water purification product and to ultimately diversify it’s product line through ingenuity and/or acquisition. In order to accomplish these goals we are redirecting the sales effort so that the Company will no longer predominantly focus on the government sector, a target with historically long lead times. In addition the Company is reviewing the entire approach to the product with an aim to 1) deepen and diversify our distribution channels, 2) lower our cost of production, 3) improve the Company's profit margin on and 4) maintain an inventory of units for immediate sale.
	The Company requires immediate capital to remain viable. The Company can give no assurance that such financing will be available on terms advantageous to the Company, or at all. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all of its operational activities. The accompanying audited consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
	Subsequent to December 31, 2013, the Company has issued approximately $190,000 of notes payable and approximately $301,000 of convertible notes payable. From January 1, 2014 until October 23, 2014, the Company issued 414,812,709 shares of common stock for the settlement of $219,620 loan principal plus $24,850 accrued interest and fees.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2013
RECENT ACCOUNTING PRONOUNCEMENTS	'
RECENT ACCOUNTING PRONOUNCEMENTS	'
	NOTE 4 – RECENT ACCOUNTING PRONOUNCEMENTS.
	In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” Under this new guidance, companies must present this unrecognized tax benefit in the financial statements as a reduction to deferred tax assets created by net operating losses or other tax credits from prior periods that occur in the same taxing jurisdiction. If the unrecognized tax benefit exceeds such credits it should be presented in the financial statements as a liability. This update is effective for annual and interim reporting periods for fiscal years beginning after December 15, 2013. The adoption of this standard is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.
	The U.S. Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08) in April 2014. This new standard raises the threshold for disposals to qualify as discontinued operations, allows companies to have significant continuing involvement and continuing cash flows and provides for new and additional disclosures of discontinued operations and individually material disposal transactions. The Company anticipates adopting the new standard when it becomes effective in the first quarter of 2015. The Company does not expect the adoption of ASU 2014-08 to have a material effect on its consolidated financial statements.
	The FASB has issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered.. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The Company is currently evaluating the effect of the ASU on its financial position, results of operations and cash flows.
	The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating the effect of the ASU on its financial position, results of operations and cash flows.
	In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard for the fiscal year ending December 31, 2016 and the Company will continue to assess the impact on its consolidated financial statements.
	The FASB and the SEC have issued certain other accounting standards updates and regulations that will become effective in subsequent periods; however, management of the Company does not believe that any of those updates would have significantly affected the Company’s financial accounting measures or disclosures had they been in effect during 2014 or 2013, and does not believe that any of those pronouncements will have a significant impact on the Company’s consolidated financial statements at the time they become effective.

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2013
PROPERTY AND EQUIPMENT	'
PROPERTY AND EQUIPMENT	'
	NOTE 5 – PROPERTY AND EQUIPMENT
	Property and equipment consist of the following at December 31, 2013 and 2012:
		2013		2012
	Leasehold improvement	$	74,945	$	74,945
	Furniture and fixtures		31,987		49,265
	Equipment		72,358		89,514
			179,290		213,724
	Accumulated depreciation and amortization		-179,290		-164,710
	Property and equipment, net	$	-	$	49,014
	Depreciation and amortization expense was approximately $15,000 and $53,000 for the years ended December 31, 2013 and 2012, respectively.
	On October 8, 2013 an eviction notice was issued by the landlord for the Company’s facilities at 160 Dupont Street. The Company abandoned the space on October 11 2013. Accordingly the Company recorded a charge of $21,720 for the loss on abandonment of property.
	During the year ended December 31, 2013 the Company sold property and equipment and recorded a gain of $9,486.

PATENTS_AND_TRADEMARKS

PATENTS AND TRADEMARKS	12 Months Ended
	Dec. 31, 2013
PATENTS AND TRADEMARKS	'
PATENTS AND TRADEMARKS	'
	NOTE 6 – PATENTS AND TRADEMARKS
	Patents and trademarks as of December 31, 2013 and 2012 consist of the following:
		2013		2012
	Patents	$	104,621	$	97,164
	Trademarks		2,720		2,720
	Total cost		107,341		99,884
	Accumulated amortization		-47,919		-41,816
	Patents and trademarks, net	$	59,422	$	58,068
	Amortization expense for the years ended December 31, 2013 and 2012 was approximately $6,100.
	The following table presents the Company's estimate for amortization expense for each of the five succeeding years and thereafter.
	Year Ended December 31,
	2014	$	6,100
	2015		6,100
	2016		6,100
	2017		6,100
	2018		6,100
	2019 and thereafter		28,922
		$	59,422

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2013
INVENTORIES	'
INVENTORIES	'
	NOTE 7 – INVENTORIES
	Inventories consist of the following at December 31, 2013 and 2012,
			2013		2012
	Raw materials	$	-	$	43,684
	Finished Goods		141,636		279,034
	Total	$	141,636	$	322,718
	During the year ended December 31, 2013 inventory in the amount of $56,344 was abandoned as a result of moving to a new facility. Our abandonment charges related to inventory have been included in “Cost of Goods Sold” in our Statements of Operations.

NET_LOSS_PER_SHARE_OF_COMMON_S

NET LOSS PER SHARE OF COMMON STOCK	12 Months Ended
	Dec. 31, 2013
NET LOSS PER SHARE OF COMMON STOCK	'
NET LOSS PER SHARE OF COMMON STOCK	'
	NOTE 8 – NET LOSS PER SHARE OF COMMON STOCK.
	Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants, convertible preferred stock and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.
	Total shares issuable upon the exercise of warrants and conversion of preferred stock and convertible promissory notes for the years ended December 31, 2013 and 2012 were as follows:
		December 31,
		2013		2012
	Warrants	176,574,286		85,652,403
	Convertible promissory notes	492,877,340		187,297,345
	Convertible preferred stock	1,545,760		1,545,760
	Total	670,997,386		274,495,508
	For the years ended December 31, 2013 and 2012, 101,547,890 and 7,101,783 warrants were included in loss per share as their exercise price was determined to be nominal.
	Fair Value
	ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.
	ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:
	·
	Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
	·
	Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.
	·
	Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.
	In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.
	Liabilities measured at fair value on a recurring basis at December 31, 2013 and 2012 are as follows:
		Quoted Prices in Active Markets for Identical Liabilities			Significant Other Observable Inputs		Significant Unobservable Inputs		Balance at
		(Level 1)			(Level 2)		(Level 3)		December 31,
	Embedded conversion feature	$	–		$	–	$	224,000	$	224,000
	Warrant liability	$	–		$	–	$	39,300	$	39,300
	Balance at December 31, 2012	$	–		$	–	$	263,300	$	263,300
	Embedded conversion feature	$	–		$	–	$	206,500	$	206,500
	Warrant liability	$	–		$	–	$	92,500	$	92,500
	Balance at December 31, 2013	$	–		$	–	$	299,000	$	299,000
	Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The Company’s Level 3 liabilities consist of derivative liabilities associated with convertible debt that contains an indeterminable conversion share price and the tainted warrants as the Company cannot determine if it will have sufficient authorized common stock to settle such arrangements.
	The following table provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets measured at fair value on a recurring basis using significant unobservable inputs during the year ended December 31, 2013 and 2012.
		Warrants			Conversion		Total
					Feature
	Balance at - January 1, 2012	$	446,400		$	68,800	$	515,200
	Change in fair value of derivative liability		-537,500			-460,800		-998,300
	Included in liabilities (debt discount)		28,100			621,000		649,100
	Included in stock based compensation		17,200			–		17,200
	Included in stockholder’s equity		85,100			-5,000		80,100
	Balance at - December 31, 2012	$	39,300		$	224,000	$	263,300
	Included in stock based compensation		4,500			–		4,500
	Change in fair value of derivative liability		-297,100			-95,900		-393,000
	Included in liabilities (debt discount)		114,000			240,000		354,000
	Included in liabilities (derivative expense)		209,800			35,400		245,200
	Included in stockholder's equity		22,000			-197,000		-175,000
	Transfers in and /or out of Level 3		–			–		–
	Balance at - December 31, 2013	$	92,500		$	206,500	$	299,000

NOTES_PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2013
NOTES PAYABLE	'
NOTES PAYABLE	'
	NOTE 9 – NOTES PAYABLE
	Notes payable and accrued interest at December 31, 2013 and 2012 consist of the following:
		December 31,
		2013			2012
		$	-	(a)	$	15,221	(a)
			75,000	(b)		75,000	(b)
			245,860	(c)		237,006	(c)
			175,841	(d)		165,628	(d)
			83,952	(e)		222,170	(e)
			-	(f)		-	(f)
			12,500	(g)		-	(g)
	Notes payable and accrued interest		593,153			715,025
	Less: Current maturities		-593,153			-706,829
	Notes payable and accrued interest, net of Current maturities	$	-		$	8,196
	(a)
	In February, 2010, the Company acquired a vehicle for business use. Cost of the vehicle is approximately $30,000 and the Company financed the entire cost. The financing term is approximately $500 per month for sixty months based on an annual interest rate of 9%. During 2013 the loan was paid in full.
	(b)
	In April 2001, the Company issued a $400,000 promissory note bearing interest at the rate of 2% per month. In consideration for the issuance of this note, 500,000 shares of common stock were issued to the note holder and a $74,000 debt discount was recorded and fully amortized in the year ended December 31, 2001. The principal balance and accrued interest was payable on September 1, 2001. The Company did not make such payment and was required to issue an additional 100,000 shares to the note holder as a penalty. The Company recorded additional interest expense of $12,300 related to the issuance of these penalty shares.
	In October 2007, the Company entered into a settlement agreement with this note holder. Under the settlement agreement, the Company became obligated to make payments of $75,000 each on or before December 31, 2007 and June 30, 2008. The June 20, 2008 payment remains unpaid. In addition, the Company was obligated to issue 2,500,000 shares of common stock to the note holder as settlement for the remaining balance due under the promissory note of $477,934. In January 2008, the Company issued 1,250,000 of the 2,500,000 shares.
	(c)
	These are unsecured notes bearing interest at rates ranging from 10% to 15% per annum, and have no specific due date for repayment. The outstanding amount of $245,860 and $237,006 include principal of $83,222 and accrued and unpaid interest of $162,638 and $153,784 as of December 31, 2013 and 2012, respectively. No demands for repayment have been made by the note holders. As of December 31, 2013, the Company is not compliant with the repayment terms of the notes and is in technical default.
	(d)
	In September 2009, the Company entered into agreements with three of the Company’s consultants and vendors to defer a total in the aggregate of $236,624 in compensation owed to them. In return, the Company issued to the three vendors each a promissory note for the deferment. The notes matured in January 2011 and interest will be accrued at 10% per annum compounded monthly. As of December 31, 2009 the Company reclassified $236,624 from current liabilities to long term liabilities.
	In February 2010, one of the above three vendors, requested to convert the note payable of $90,000 principal plus $5,781 accrued interest into the Company’s common stock. The request was approved by Board of Directors on February 19, 2010 and the conversion price was set at $0.055 which was the closing price published on OTCBB.com on the date of the approval of such request. On March 2, 2010, 1,741,464 shares were issued for such conversion.
	As of December 31, 2013 and 2012, the Company is reflecting a liability of $175,841 and $165,628 which includes accrued interest of $69,217 and $59,004, respectively. As of December 31, 2013 the Company is not compliant with the repayment terms of the notes and is in technical default.
	(e)
	In 2012, the Company raised $75,000 through issuing multiple promissory notes. These notes bear interest rate of 10% per annum and are due and payable between October 19 and October 26, 2012. As of December 31, 2012, the Company is reflecting $76,452 which includes $1,452 of accrued interest.
	At the request of multiple lenders, the Company converted $207,770 of note payable and accrued interest to convertible notes payable in 2012.
	In September, at the request of the lender, the Company converted $100,000 of convertible notes payable to $185,000 of notes payable. The newly issued notes payable bear interest at rates of 6% and have maturity dates in December 2012 through January 2013. The Company is required to repay the notes payable in 5 installments with the final payment of $65,000 in January 2013. As of December 31, 2012, the Company repaid $45,337 principal which consist $20,000 cash payment and $25,337 in issuing 8,774,761 shares of common stock.
	During the year ended December 31, 2013, at the request of a lender the Company repaid $139,663 of debt and accrued interest for $14,200 in cash and the issuance of 23,021,012 shares of common stock for the settlement of $125,463 of the remaining balance.
	As of December 31, 2012 and 2011, the Company is reflecting a liability of $83,952 and $222,170 which includes accrued interest of $8,952 and $7,507, respectively. As of December 31, 2013 the Company is not compliant with the repayment terms of the notes and is in technical default.
	(f)
	On December 16, 2011, the Company issued a $140,000 promissory note bearing interest at the rate of 15% per annum. This note shall be payable in one monthly installment with the first such installment to be paid on the 15th day of March 2012. The Company may also, at its discretion, permit repayment to be made by assignment of its accounts receivable due from the State of Alaska.
	As of December 31, 2011, the Company is reflecting a liability of $140,978 which includes accrued interest of $978.
	On March 12, 2012, the Company repaid the Note Holder, principal and interest of total $145,794.
	On September 17, 2013, the Company issued a $12,500 promissory note bearing interest at the rate of 5% per annum. This note matures on December 31, 2014. As of December 31, 2013 the outstanding principal balance on the note was $12,500.
	(g)
	As of December 31, 2013, the Company is in technical default with the repayment terms of the notes payable outstanding.

CONVERTIBLE_PROMISSORY_NOTES_P

CONVERTIBLE PROMISSORY NOTES PAYABLE	12 Months Ended
	Dec. 31, 2013
CONVERTIBLE PROMISSORY NOTES PAYABLE	'
CONVERTIBLE PROMISSORY NOTES PAYABLE	'
	NOTE 10 – CONVERTIBLE PROMISSORY NOTES PAYABLE
	(a)
	As of December 31, 2010, the Company has cumulative net liabilities of $428,475, net of $241,657 debt discount. The liability includes $645,000 unpaid convertible notes principal and $25,132 accrued interest for all the convertible notes the Company entered into prior to January 1, 2011. These notes mature in one year from the date issued and bear interest at 10% per annum and are convertible at the option of the holder in to shares of common stock. The conversion prices range from $0.044 to $0.07. As of January 1, 2011, the Company was not in compliance with the repayment terms of these notes.
	In 2011, the Company raised $300,000 through debt financing from multiple lenders. The Company issued each lender a convertible promissory note in the principal amount of money lender loaned to the Company. The promissory note matures in one year and bears interest at 10% per annum and is convertible at the option of the holder in to shares of common stock. The conversion prices range from $0.067 to $0.157. In addition the Company granted 634,229 warrants to the note holders. The warrants have a life of 5 years and are fully vested on the date of the grant, the exercise price of the warrants ranges from $0.084 to $0.1884.
	The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 ”Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and were marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of these note $300,000 was recorded net of a discount of $57,638. The debt discount consisted of approximately $13,719 related to the fair value of the embedded conversion option and approximately $43,919 related to the fair value of the warrants. The debt discount was being charged to interest expense ratably over the term of the convertible note.
	During the year ended December 31, 2011, multiple lenders requested to convert total aggregated $125,000 principal plus accrued interest of $14,097 into the Company’s common stock. The Company issued total aggregated 2,539,747 shares of common stock in connection with such conversions.
	In 2012, the Company raised $768,500 through debt financing from multiple lenders. The Company issued each lender a convertible promissory note in the principal amount of money lender loaned to the Company. The Company issued the lender for each loan a convertible promissory note bearing interest at rates of 8% to 12% per annum with maturity dates of September 15, 2012 to November 16, 2013. The loans and accrued interest are to be paid on the maturity dates. Each loan is evidenced by the promissory note the Company issued to the lender which contains conversion clauses that allow the lenders the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. Each of the notes contains variable conversion prices representing discount rate between 5% and 50% of market price. In addition, the Company also issued total 1,933,333 warrants to the lenders to purchase additional shares of common stock at exercise of $0.072 to $0.05. These warrants have term of 5 years. In addition a note-holder received 4,375,000 shares of common stock in consideration for entering into the note.
	The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and were marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of these notes were recorded net of a discount of $649,100. The debt discount was being charged to interest expense ratably over the term of the convertible note.
	In addition, the Company incurred approximately $130,000 of financing cost related to these transactions which will be amortized over the term of the loans.
	On October 4, 2013, at the request of the lender due to default, the Company converted $303,499 of convertible notes and accrued interest into a new convertible note in the amount of $531,431. The increase in principal was due to amounts charged by the lender for penalties, interest, legal and other fees. The newly issued note bears interest at rates of 18% per annum and is due on demand. The lender may convert all or any portion of the outstanding principal, accrued and unpaid interest, and any other sums due and payable under the Revolving Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest daily volume weighted average price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to the lender not being able to beneficially own more than 4.99% of our outstanding common stock upon any conversion. The conversion price is subject to anti-dilution protection in the event that the Company issues additional equity securities at a price less than the conversion price. On March 10, 2014, TCA accelerated the outstanding principal balance, interest, calculated at the default rate of 18%, and all sums due under the original note and any amendments. (see Note 13 – Litigation)
	During the year ended December 31, 2012, multiple lenders requested to convert total aggregated $664,576 principal plus accrued interest of $29,955 into the Company’s common stock. The Company issued total aggregated 146,134,552 shares of common stock in connection with such conversions.
	During the year ended December 31, 2013, multiple lenders requested to convert total aggregated $342,151 principal plus accrued interest of $57,519 into the Company’s common stock. The Company issued total aggregated 84,053,707 shares of common stock in connection with such conversions.
	During the year ended December 31, 2013, the Company repaid principal of $32,500.
	As of December 31, 2013, the Company is reflecting liabilities of $1,055,272 including accrued interest of $148,843 and the Company is not in compliance with the repayment terms with certain notes and is currently in technical default.
	(b)
	On August 3, 2011, the Company borrowed $125,000 from a private investor and issued to the investor a secured convertible promissory note in the principal amount of $125,000. The note matures on December 1, 2011 and bears interest at a stated rate of 8% per annum and the note is convertible into shares of common stock of the Company at a 30% discount from the current market price (as defined in the Note). The Company has the right to redeem the Note at any time by paying the outstanding principal amount of the Note multiplied by a premium according to the following schedule, plus all accrued interest: 120% of the outstanding principal amount if redeemed within 90 days after the issuance date; 125% of the outstanding principal amount if redeemed within 180 days after the issuance date; 130% of the outstanding principal amount if redeemed after 180 days after the issuance date. The Note is further guaranteed by two officers of the Company and secured by stock pledge agreements with each officer, pursuant to which each of the officers has pledged 2,000,000 shares of the Company’s common stock owned by them as collateral to secure payment of the Note. In connection with the issuance of the Note, the Company also issued to the investor a common stock purchase warrant, expiring August 3, 2018, to purchase 1,250,000 shares of common stock at an exercise price of $0.10 per share.
	The Company accounted for the issuance of the convertible promissory notes in accordance with ASC 815” Derivatives and Hedging.” Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note of $125,000 was recorded net of a discount of $125,000. The debt discount consisted of $83,900 to the fair value of the warrants and $41,100 related to the fair value of the embedded conversion option. In addition to the $125,000 mentioned above, the Company recorded a charge in the amount of $15,900 which represents the fair value of conversion options in excess of the debt discount recorded. The debt discount will be charged to interest expense ratably over the term of the convertible notes.
	In 2012, the lender requested to convert principal $125,000 plus accrued interest of $6,685 into the Company’s common stock. The Company issued 3,581,697 shares of common stock in connection with such conversion.
	(c)
	On January 8, 2013 for gross proceeds of $25,000 the Company issued a convertible promissory note bearing interest at the rate of 10% per annum with a maturity date of January 8, 2014. The loan and accrued interest are to be paid on the maturity date. The promissory note contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at a conversion rate of $0.03 per share. In addition, the Company also issued 1,666,667 warrants to the lender to purchase additional shares of common stock at an exercise price of $0.0036 per share. These warrants are fully vested and have a term of 5 years.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $13,600. The debt discount relates to the beneficial conversion feature embedded in the conversion option and the fair value of the warrants attached to the notes. The debt discount is charged to interest expense ratably over the term of the convertible note.
	During the year ended December 31, 2013, the note holder requested to convert total aggregated $25,000 principal plus accrued interest of $167, into the Company’s common stock. The Company issued total aggregated 8,388,890 shares of common stock in connection with such conversion.
	(d)
	On May 16, 2013, the Company in conjunction with an existing note holder entered into a new loan agreement with a new lender for the sale and transfer of a $20,000 note plus $4,895 accrued interest this note matured and was in technical default with the repayment provisions of the terms of the agreement. The Company cancelled the original note and issued the new lender a convertible promissory note for $29,895 bearing interest rate of 10% per annum with a maturity date of January 1, 2014. The loan and accrued interest are to be paid on the maturity date. The promissory note contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at a conversion rate of the lesser of a.) 60% of the low traded price of the Company’s common stock for the twenty trading day period immediately preceding the date at the which Holder, by written notice gives notice to the Company of its election to convert or b.) $0.01 per share. The Company recorded $5,000 loan cost in connection with the increase of the principal included in deferred financing costs. The loan cost will be amortized over the life of the loan.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $19,930. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.
	During the year the Company was charged interest and penalties by the note holder totaling $33,515.
	During the year ended December 31, 2013, the note holder requested to convert total aggregated $29,895 principal plus accrued interest and penalties of $15,435, into the Company’s common stock. The Company issued total aggregated 10,000,000 shares of common stock in connection with such conversion.
	(e)
	On May 22, 2013, the Company entered into a loan agreement (“credit facility) for the principal sum of $335,000 less any fees. The components of the credit facility are $300,000 proceeds of the loan plus $35,000 original issue discount. The maturity date is one year from the effective date of each draw made by the Company. The loan and accrued interest are to be paid on the maturity date. In addition after 90 days that the amount drawn is outstanding a one-time interest charge of 12% will be charged and added to the principal sum. The promissory note contains conversion clauses that allow the lender, at any time from 180 days after the Effective Date, the option to convert the amount payable plus all accrued and unpaid interest due under the agreement into common stock at a conversion price per share of the lesser of $0.018 or 60% of the lowest trade price in the 25 trading days preceding the conversion.
	The Company received net cash proceeds of $65,000 upon entering the agreement on May 22, 2013 and recorded $6,500 loan cost in connection with this transaction. The loan costs have been included in deferred financing costs and will be amortized through the maturity date of the loan.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $41,000. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note. On August 20, 2013, the Company recorded a $8,580 one-time interest expense and added such amount to the principal of the May 22, 2013 draw when the Company failed to repay the loan within 90 days.
	On August 22, 2013 the Company drew down from the credit facility $35,500 and received net cash proceeds of $30,000 after the associated legal fees. The Company recorded $5,500 loan cost in connection with this transaction and the loan cost will be amortized through the maturity date of the loan. The gross proceeds from the sale of the note are recorded net of a debt discount of $29,000. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.
	On October 23, 2013, the Company drew down from the credit facility $55,000 and received net cash proceeds of $50,000 after the associated legal fees. The Company recorded $5,000 loan cost in connection with this transaction and the loan cost will be amortized through the maturity date of the loan. The gross proceeds from the sale of the note are recorded net of a debt discount of $55,000. The debt discount relates to fair value of the conversion option of the note. The debt discount is charged to interest expense ratably over the term of the convertible note. The fair value of the conversion option on the date of issuance in excess of the face amount of the note was recorded to interest expense on the date of issuance.
	On July 11, 2013, the Company in conjunction with an existing note holder entered into a new loan agreement with a new lender for the sale and transfer of a $20,000 promissory note plus $5,095 accrued interest this note matured and was in technical default with the repayment provisions of the terms of the agreement. The Company cancelled the original promissory note and issued the new lender a convertible promissory note for $25,000 with a maturity date of September 30, 2013. The convertible promissory note contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at a conversion rate of the lesser of (a.) $0.015 or (b) 50% of the lowest closing bid price for the Company’s common stock during the twenty (20) trading day period immediately preceding the date at the which Holder, by written notice gives notice to the Company of its election to convert. The Company recorded $33,000 debt discount and the excess fair value of 8,000 was charged to interest expense upon the consummation of the arrangement.
	During the year ended December 31, 2013, the note holder requested to convert total aggregated $25,470 principal plus accrued interest of $0, into the Company’s common stock. The Company issued total aggregated 4,209,917 shares of common stock in connection with such conversion.
	(f)
	A convertible promissory note was issued on August 19, 2013 in the amount of $25,000 to a lender. The note matures on August 19, 2014 with interest at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.015 per shares. In addition, 8,333,333 Warrants were issued at a price of $.003 per share. The warrants are fully vested and have a life of five years from date of issuance.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $121,400. The debt discount relates to the beneficial conversion feature embedded in the conversion option and the fair value of the warrants attached to the notes. The excess fair value of $96,400 was charged to interest expense on the date of the agreement and the debt discount is charged to interest expense ratably over the term of the convertible note.
	(g)
	On July 25, 2013, the Company was advanced $10,000 from a lender and subsequently on August 16, 2013, the lender funded another $25,000. The Company issued a convertible promissory note for the total amount of $35,000 to the lender. The note matures in one year from the issuance date with interest at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.005 per shares. In addition, 5,833,333 warrants were issued with an exercise price of $. 006 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $159,300. The debt discount relates to the beneficial conversion feature embedded in the conversion option and the fair value of the warrants attached to the notes. The excess fair value of $124,300 was charged to interest expense on the date of the agreement and the debt discount is charged to interest expense ratably over the term of the convertible note
	(h)
	On September 5, 2013 the Company issued a convertible promissory note for $ 5,000. The note matures in one year from the issuance date with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.005 per shares. In addition, 200,000 Warrants were issued with an exercise price of $0.006 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $5,700. The debt discount relates to the beneficial conversion feature embedded in the conversion option and the fair value of the warrants attached to the notes. The excess fair value of $700 was charged to interest expense on the date of the agreement and the debt discount is charged to interest expense ratably over the term of the convertible note. The debt discount is charged to interest expense ratably over the term of the convertible note.
	(i)
	On September 12, 2013 the Company issued a convertible promissory note for $ 100,000. The note matures in one year from the issuance date with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0085 per share. In addition, 10,416,666 warrants were issued with an exercise price of $0.0096 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $82,400. The debt discount relates to fair value of the warrants attached to the notes. The debt discount is charged to interest expense ratably over the term of the convertible note.
	(j)
	On December 10, 2013 the Company issued a convertible promissory note for $ 35,000. The note matures in one year from the issuance date with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.005 per share. In addition, 5,833,333 warrants were issued with an exercise price of $0.006 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	The Company accounted for the issuance of the convertible promissory note and the warrants attached to the note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $35,000. The debt discount relates to fair value of the conversion option and the warrants attached to the notes. The debt discount is charged to interest expense ratably over the term of the convertible note. The fair value of the conversion option and warrants on the date of issuance in excess of the face amount of the note was recorded to interest expense on the date of issuance.
	(k)
	During the year ended December 31, 2013 the Company issued a total of 121,376,671 shares of common stock upon requests from note holders to convert loans with principal plus accrued interest totaling $57,686 based on the terms set forth in the loans.
	As of December 31, 2013, the Company is in technical default with the repayment terms of the convertible notes payable.
	Convertible promissory notes payable and accrued interest at December 31, 2013 and 2012 consists of the following:
		December 31,
		2013		2012
	Convertible notes payable	$	1,449,619	$	1,191,716
	Discount on convertible notes		-210,781		-80,606
	Convertible notes payable, net		1,238,838		1,111,110
	Less current maturities		-1,238,838		-1,111,110
	Long-Term Portion	$	-	$	-

CONVERTIBLE_NOTES_AND_NOTES_PA

CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	12 Months Ended
	Dec. 31, 2013
CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	'
CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	'
	NOTE 11 – CONVERTIBLE NOTES AND NOTES PAYABLE – OFFICERS & DIRECTOR
	Convertible notes and notes payable – Officers & Director and accrued interest at December 31, 2013 and 2012 consists of the following:
		2013			2012
		$	435,382	(a)	$	406,682	(a)
			222,322	(b)		208,322	(b)
			54,008	(c)		57,260	(c)
			39,113	(d)		71,490	(d)
			46,378	(e)		42,378	(e)
			25,000	(f)		25,000	(f)
			5,051	(g)		-	(g)
	Total		827,254			811,132
	Less: Current maturities		-827,254			-811,132
	Convertible notes and notes payable – Officers & Director and accrued interest, net of Current maturities	$	-		$	-
	(a)
	In September 2009, the Company entered into agreements with the Chief Executive Officer and Chief Financial Officer together to defer a total of $287,000 in compensation owed to them as of September 30, 2009. In return, the Company issued to the Chief Executive Officer and Chief Financial Officer each a promissory note for the deferment. The notes mature in January 2011 and interest will be accrued at 10% per annum compounded monthly.
	As of December 31, 2013 and 2012, the Company is reflecting a liability of $435,382 and $406,682 which includes $148,382 and $119,682 of accrued interest, respectively and the Company is not compliant with the repayment terms.
	(b)
	On April 7, 2010, the Company’s Chief Executive Officer, and the Company’s former Chief Financial Officer each made loans of $100,000 to the Company. The loans accrue interest at the rate of 7% per annum. In addition, the Company issued warrants to each officer to purchase 431,034 shares of common stock at an exercise price of $0.059 per share. The loans are due and payable by or on October 7, 2010. The interests accrued on the loans are to be paid on the 7th day of each month until the loans mature and paid off. The loans were evidenced by the promissory notes the Company issued to the two officers which each contain a conversion clause that allow the officers at the officer’s sole option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. The conversion price was set at $0.059 per share, which was the closing market price of the common stock as of the closing date of the loans.
	The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 “Derivatives and Hedging.” Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and were marked to market through earnings at the end of each reporting period. The gross proceeds from the sales of the notes of $200,000 were recorded net of a discount of $101,600. The debt discount consisted of $34,800 related to the fair value of the warrants and approximately $66,800 related to the fair value of the embedded conversion option. The debt discount will be charged to interest expense ratably over the term of the convertible note.
	As of December 31, 2013, and 2012, the Company is reflecting a liability of $222,322 and $208,322 which includes $22,322 and $8,322 accrued interest, respectively and the Company is not compliant with the repayment terms.
	(c)
	On February 7, 2011, the Company’s Chief Executive Officer and the Company’s former Chief Financial Officer each made loans of $50,000 to the Company. The loans accrue interest at the rate of 10% per annum. In addition, the Company issued warrants to each officer to purchase 89,928 shares of common stock at an exercise price of $0.139 per share. The loans are due and payable by or on February 7, 2012. The loan is to be paid on the maturity date and the accrued interest is to be paid at the end of each month. The loans were evidenced by the promissory notes the Company issued to the two officers which each contain a conversion clause that allow the officers at the officer’s sole option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. The conversion price was $0.139 per share, which was the closing market price of the common stock as of the closing date of the loans.
	The Company accounted for the issuance of the notes in accordance with ASC 470 “Debt” and accordingly the gross proceeds of $100,000 from the sales of the notes were recorded net of a debt discount of $33,612. The debt discount related to the relative fair value of the warrants and was charged to interest expense ratably over the term of the loan.
	In 2011, the Company paid repaid $40,000 principal and paid $6,189 accrued interest. In 2012, the Company repaid $6,000 principal and paid $3,050 accrued interest. In 2013, the Company paid repaid $8,000 in principal.
	As of December 31, 2013, and 2012, the Company is reflecting a liability of $54,008 and $57,260 which includes $8,008 and $3,260 accrued interest, respectively and the Company is not compliant with the repayment terms.
	(d)
	On March 16, 2011, the Company’s Chief Financial Officer made a loan of $85,000 to the Company. The loan accrues interest at the rate of 10% per annum. In addition, the Company issued warrants to purchase 174,180 shares of common stock at an exercise price of $0.122 per share. The loan is due and payable by or on March 16, 2012. The loan is to be paid on the maturity date and the accrued interest is to be paid at the end of each month. The loan is evidenced by the promissory note the Company issued to the officer which contains a conversion clause that allow the officer at the officer’s sole option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. The conversion price was $0.122 per share, which was the closing market price of the common stock as of the closing date of the loans.
	The Company accounted for the issuance of the note in accordance with ASC 470 “Debt” and accordingly the gross proceeds of $85,000 from the sales of the note was recorded net of a debt discount of $28,610. The debt discount related to the relative fair value of the warrants and is being charged to interest expense ratably over the term of the note.
	In 2012, the Company repaid $18,000 in principal. In 2013, the Company repaid $36,500 in principal
	As of December 31, 2013, and 2012, the Company is reflecting a liability of $39,113 and $71,490 which includes $8,613 and $4,490 accrued interest, respectively and the Company is not compliant with the repayment terms.
	(e)
	On March 28, 2011, the Company’s Chief Financial Officer made a loan of $40,000 to the Company. The loan pays interest monthly at the rate of 10% per annum. In addition, the Company issued warrants to purchase 83,333 shares of common stock at an exercise price of $0.12 per share. The loan is due and payable by or on March 28, 2012. The loan is to be paid on the maturity date and the accrued interest is to be paid at the end of each month. The loan is evidenced by the promissory note the Company issued to the officer which contains a conversion clause that allow the officer at the officer’s sole option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. The conversion price was $0.12 per share, which was the closing market price of the common stock as of the closing date of the loans.
	The Company accounted for the issuance of the note in accordance with ASC 470 “Debt” and accordingly the gross proceeds of $40,000 from the sales of the note was recorded net of a debt discount of $13,472. The debt discount related to the relative fair value of the warrants and is being charged to interest expense ratably over the term of the note.
	As of December 31, 2013 and 2012, the Company is reflecting a liability of $46,378 and $42,378 which includes $6,378 and $2,378 accrued interest, respectively. The Company is not compliant with the repayment terms.
	(f)
	On February 13, 2012 and on October 5, 2012, the Company’s Chief Executive Officer each made a short term loan of $10,000 and $15,000 to the Company. These loans were intended to be repaid within 2 months. No documents were prepared nor interest accrued. As of December 31, 2013 and 2012, the Company is reflecting a liability of $25,000. The Company is not compliant with the repayment terms.
	(g)
	On January 3, 2013, the Company’s Chief Executive Officer each made a short term loan of $9,051 to the Company. This loan was intended to be repaid within 2 months. No documents were prepared nor interest accrued. During 2013 $4,000 was repaid. As of December 31, 2013 the Company is reflecting a liability of $5,051. The Company is not compliant with the repayment terms.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2013
RELATED PARTY TRANSACTIONS	'
RELATED PARTY TRANSACTIONS	'
	NOTE 12 – RELATED PARTY TRANSACTIONS.
	(a)
	On January 2, 2013, the Company issued a total of 12,820,512 warrants to purchase common stock to its four directors, including warrants issued to its Chief Executive Officer and former Chief Financial Officer, each of which received 3,205,128 warrants for their first quarter of 2013 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved replacing directors’ annual compensation of $50,000 with three year warrants payable quarterly. The warrants have a term of three years and are fully vested on the date of issuance. The Company recorded $70,800 of stock-based compensation in connection with this issuance.
	(b)
	On March 18, 2013, the Company issued to its Chief Executive Officer 15,000,000 shares of common stock and warrants to purchase an additional 15,000,000 shares of common stock at the exercise price of $0.0033 per share. The issuance was approved by the Company’s Compensation Committee on February 11, 2013. The warrants have a term of five years. The shares and warrants are fully vested on the date of grant. The Company recorded $188,700 of stock-based compensation which includes $97,500 for the share issuance and $91,200 for the warrants granted.
	(c)
	On March 18, 2013, the Company issued to its former Chief Financial Officer 10,000,000 shares of common stock and warrants to purchase an additional 10,000,000 shares of common stock at the exercise price of $0.0033 per share. The issuance was approved by the Company’s Compensation Committee on February 11, 2013. The warrants have a term of five years. The shares and warrants are fully vested on the date of grant. The Company recorded $125,800 of stock-based compensation which includes $65,000 for the share issuance and $60,800 for the warrants granted.
	(d)
	On April 5, 2013, the Company issued a total of 3,846,152 warrants to purchase common stock to its four directors, including warrants issued to its Chief Executive Officer and Chief Financial Officer, each of which received 961,538 warrants for their second quarter of 2013 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved replacing directors’ annual compensation of $50,000 with three year warrants payable quarterly. The warrants have a term of three years and are fully vested on the date of issuance. The Company recorded $27,600 of stock-based compensation in connection with this issuance.
	(e)
	On July 1, 2013, the Company issued a total of 2,702,704 warrants to purchase common stock to its four directors, including warrants issued to its Chief Executive Officer and Chief Financial Officer, each of which received 675,676 warrants for their third quarter of 2013 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved replacing directors’ annual compensation of $50,000 with three year warrants payable quarterly. The warrants have a term of three years and are fully vested on the date of issuance. The Company recorded $40,800 of stock-based compensation in connection with this issuance.
	(f)
	On July 7, 2013, the Company issued a total of 650,000 warrants to purchase common stock to its employees. The warrants have a term of three years and are fully vested on the date of issuance. The Company recorded $11,700 of stock-based compensation in connection with this issuance.
	(g)
	On June 26, 2012 the Board of Directors of the Company designated and authorized the Series B Preferred Stock ("Series B") as set forth in a Certificate of Designation that was filed with the Secretary of State of the State of Delaware. The Series B has a par value of $0.001 per share, no rights to dividends but provides for liquidation rights which entitle the holder to a pro-rata share of net assets. The Series B carried no conversion provisions. Subsequent to March 31, 2013 all outstanding shares of Series B were returned by the holder for no consideration to the Company, and the Company’s Board of Directors authorized cancellation of the Series B. The Certificate of Amendment cancelling the Series B Preferred Stock was filed with the State of Delaware on April 16, 2013.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2013
COMMITMENTS AND CONTINGENCIES	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 13 – COMMITMENTS AND CONTINGENCIES
	Operating Leases
	25 Fairchild Ave
	Effective as of July 1, 2008, the Company entered into a seven-year lease for 5,300 square feet of space in Plainview, New York. The facility is to serve as the Company’s executive offices, sales office, showroom and an assembly area.
	In March 2012 management exercised a “Good Guy Clause” in its lease and abandoned the space at 25 Fairchild Avenue. Accordingly the Company recorded a charge of $34,707 for the loss on abandonment of property. The Company continues to accrue rent and rent related expenses per the Lease agreement. The Company is a defendant in a suit in the Supreme Court of the State of New York, County of Nassau, filed by Fairchild Warehouse Associates, LLC, as plaintiff, for recovery of past rental payments for the Company’s former office space at 25 Fairchild Avenue, Plainview, N.Y. 11803, with money damages, as of February 2014, requested in the amount of $ 475,930 which have been accrued for as of December 31, 2013. During 2013 the Company recorded rent and rent related expenses of $341,849 which includes a charge of $229,234 relating to the lawsuit.
	160 Dupont Street
	On May 24, 2010, effective July 1, 2010, the Company entered into a two-year lease in Plainview, New York. The facility is to serve as the Company’s production facilities, as well as its’ headquarters. Under the terms of the lease the Company paid a deposit of approximate $12,000. The minimum monthly lease payments due under this lease are approximately $6,000 for the period July 1, 2010 through June 30, 2011 and approximately $10,700 for the period July 1, 2011 through June 30, 2012.
	On October 8, 2013 an eviction notice was issued by the landlord for the Company’s facilities at 160 Dupont Street. The Company abandoned the space on October 11 and immediately moved to 485 Underhill Boulevard, Syosset N.Y.
	485 Underhill Blvd.
	In October 2013 the Company entered into an operating lease for its Syosset N.Y. office facility under a month-to-month agreement starting in October 2013. The Company will pay monthly rental payments of $3,500. The Company exited the space in July 2014 and moved to 35 East Mall, Plainview N.Y.
	35 East Mall
	In June 2014 the Company entered into an operating lease for its Plainview N.Y. office facility for a period of six months starting in July 2014. The Company will pay monthly rental payments of $1,050. The lease may be renewed in six month increments, with forty-five days’ notice and is subject to a 5% increase per annum.
	Litigation
	Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.
	In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.
	If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.
	Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. As of December 31, 2013, the Company has the following litigation outstanding.
	The Company is a defendant in a suit in the Supreme Court of the State of New York, County of Nassau, filed by Fairchild Warehouse Associates, LLC (“Fairchild”), as plaintiff, for recovery of past rental payments for the Company’s former office space at 25 Fairchild Avenue, Plainview, New York 11803, with money damages, as of February 2014, requested in the amount of $475,930, which have been accrued for and included in accounts payable and accrued liabilities as of December 31, 2013. An inquest is set to begin on December 3, 2014 to determine the amount of money damages due on Fairchild’s claim.
	The Company on April 4, 2013, was served with a summons and complaint, filed with the Supreme Court of the State of New York, County of New York, Levin Consulting Group, LLC (“Levin”), as plaintiff, where the plaintiff is claiming that additional shares of the Company’s Common Stock are issuable by the Company to plaintiff in connection with the exercise by plaintiff of a common stock purchase warrant issued by the Company. The warrant was originally issued contemporaneously with the issuance of a $20,000 promissory note to Levin. In June 2014 the Company entered into a settlement and has agreed to issue a convertible promissory note in the amount of $50,000 to the plaintiff. The convertible note matures on December 31, 2015 and accrues interest at 10% per annum. The holder may convert all or any portion of the outstanding principal and accrued and unpaid interest due and payable under the note into shares of the Company’s common stock at a conversion price equal to 50% of the lowest closing bid price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to the lender not being able to beneficially own more than 9.999% of our outstanding common stock upon any conversion. If the closing bid price for the common stock on the date in which the conversion shares are deposited into the holders brokerage account and the holder may execute trades of the conversion shares (“the “Clearing Date”) then the conversion price shall be adjusted such that the discount be taken from the closing bid price on the Clearing Date. The original $20,000 note remains outstanding. As of December 31, 2013 the Company has accrued a $50,000 loss as a result of the settlement and is included in accounts payable and accrued liabilities.
	The Company is in default under a May 30, 2012, Securities Purchase Agreement entered into with TCA Global Credit Master Fund, LP (“TCA”), providing for the issuance of $275,000 principal amount of senior secured redeemable and convertible debentures due November 30, 2012. On October 4, 2013, at the request of the lender due to default, the Company converted $303,499 of convertible notes and accrued interest into a new convertible note in the amount of $531,431. The increase in principal was due to amounts charged by the lender for penalties, interest, legal and other fees. The newly issued note bears interest at rates of 18% per annum and is due on demand. The lender may convert all or any portion of the outstanding principal, accrued and unpaid interest, and any other sums due and payable under the Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest daily volume weighted average price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to the lender not being able to beneficially own more than 4.99% of our outstanding common stock upon any conversion. The conversion price is subject to anti-dilution protection in the event that the Company issues additional equity securities at a price less than the conversion price. On March 10, 2014, TCA accelerated the outstanding principal balance, interest, calculated at the default rate of 18%, and all sums due under the original note and any amendments. In August 2014 a default final judgment was entered against the Company concluding that TCA is entitled to damages in the amount of $610,349, to foreclose upon the security interests, and to recover attorneys’ fees and costs incurred by TCA. In addition prejudgment interest shall be assessed at a rate of 18% per annum and post judgment interest shall be assessed at a rate of 4.75% per annum. As of December 31, 2013 the Company is reporting a liability of $554,814 related to the TCA claim and is included in convertible notes payable.
	On November 27, 2013, the Company entered into a settlement agreement with Tarpon Bay Partners LLC (“Tarpon”), a related party. The manager of Tarpon is Stephen Hicks, the President of the Company. Tarpon previously purchase outstanding liabilities of the Company from TCA in the amount of $506,431 and Designs and Project Development Corporation (a former landlord) in the amount of $56,429. Per the terms of the settlement the Company was to issue Tarpon shares of common stock in one or more tranches as necessary, and subject to adjustment and ownership limitations, and a convertible promissory note in the principal amount of $75,000. The Company failed to issue shares to Tarpon and in the first quarter of 2014 TCA rescinded its liabilities purchase agreement with Tarpon. As of December 31, 2013 the Company is reporting a liability of $57,484 related to the Designs and Project Development Corporation claim and is included in notes payable and the $506,431 related to TCA has been included in convertible promissory notes.
	On January 31, 2014, in conjunction with the settlement agreement outlined above, the Company issued Tarpon a convertible promissory note in the principal amount of $75,000. The convertible note matures one year from the date of issuance with interest at 10% per annum. The convertible promissory note shall have no registration rights and shall be convertible into the common stock of the Company at any time at a conversion price equal to 75% of the low closing bid price for the twenty days prior to conversion.
	The Company was notified by an April 22, 2013 letter from The Depository Trust Company (“DTC”) that DTC had determined to impose a restriction on physical deposit and on Deposit/Withdrawal At Custodian (“DWAC”) electronic deposit transactions (referred to as a “deposit chill”) on the Company’s common stock. The effect of the deposit chill was that, for the period April 22, 2013 through August 6, 2013, when the deposit chill was lifted following submissions by the Company, no new shares of the Company’s common stock were accepted for deposit with DTC for electronic transfer. As of October 2014 the restriction had not been lifted.
	An eviction notice was issued on October 8 by the landlord for 160 Dupont Street, Five Towns Realty Associates, Inc (“Five Towns Realty”). There is currently an outstanding balance of $54,739 that is subject to a lawsuit and is included in accounts payable and accrued liabilities at December 31, 2013. The Company is currently in negotiations with Five Towns Realty to reach a settlement.
	An action was commenced on March 22, 2012, in the Supreme Court of the New York for the County of Nassau, by Lazar, Sanders Thaler & Associates, LLP, a dissolved accounting firm of which Terry R. Lazar, the Company’s former CFO was a member. Among the parties named as defendants were Mr. Lazar and the Company. The claim was made that the Company owned fees to the plaintiff and/or that such fees were paid to Terry Lazar who never forwarded them to the plaintiff. Mr. Lazar undertook the defense of the action on his behalf and on behalf of the Company.
	The matter proceeded to inquest and the court awarded judgment to the plaintiff against the Company in the sum of $25,000. Adding interests and costs to the awarded amount, judgment has been entered against the Company in the total sum of $36,613. An appeal has been taken from the judgment. The appeal has been perfected by the filing of the record and brief in the Supreme Court of the state of New York. As of December 31, 2013 the Company is reporting a liability of $36,613 related to the judgment.

STOCKHOLDERS_DEFICIENCY

STOCKHOLDERS' DEFICIENCY	12 Months Ended
	Dec. 31, 2013
STOCKHOLDERS' DEFICIENCY	'
STOCKHOLDERS' DEFICIENCY	'
	NOTE 14 – STOCKHOLDERS' DEFICIENCY.
	During the year ended December 31, 2013, the Company recorded the following transactions:
	Debt
	During the year ended December 31, 2013, the Company issued a total of 121,376,671 shares of common stock upon the requests from note holders to convert principal plus accrued interest totaling $490,871 into the Company’s common stock based on the terms set forth in the loans. The conversion rates were from $0.0009 to $0.014 per share
	During the year ended December 31, 2013, the Company issued a total of 23,021,012 shares of common stock to settle notes payable and accrued interest of $125,463.
	On February 4, 2013, the Company issued 4,856,726 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $10,199 of interest expense for such issuance.
	On July 15, 2013, the Company issued 526,312 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $7,895 of interest expense for such issuance.
	On October 14, 2013, the Company issued 2,078,972 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $14,345 of interest expense for such issuance.
	On October 22, 2013, the Company issued 1,582,546 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $9,495 of interest expense for such issuance.
	Cash
	Through Equity Financing:
	During the year ended December 31, 2013, for cash proceeds of $570,800 the Company sold 106,066,743 shares of common stock and warrants to purchase additional 26,516,687 shares of common stock at exercise prices of $0.0039 to $0.017 per share. The warrants have a term of three years and are fully vested on the date of issuance.
	During the year ended December 31, 2013, for gross proceeds of $64,514, the Company issued 11,609,661 shares of common stock to multiple investors who exercised their warrants to purchase shares of common stock. The exercises prices ranged from $0.0035 to $0.0184.
	On August 27, 2013 the Company received proceeds of $10,500 for the exercise of 1,093,750 warrants as of December 31, 2013 the shares have not been issued and accordingly the Company recorded the liability for the share issuance.
	On July 9, 2013 the Company received proceeds of $27,923 for the exercise of 2,389,817 warrants as of December 31, 2013 the shares have not been issued and accordingly the Company recorded the liability for the share issuance.
	Services
	On March 18, 2013, the Company issued to its Chief Executive Officer 15,000,000 shares of common stock and warrants to purchase additional 15,000,000 shares of common stock at the exercise price of $0.0033 per share. The issuance was approved by the Company’s Compensation Committee on February 11, 2013. The warrants have a term of five years. Both shares and warrants are fully vested on the date of grant. The Company recorded $188,700 of stock-based compensation which includes $97,500 for the shares issuance and $91,200 for the warrants granted.
	On March 18, 2013, the Company issued to its former Chief Financial Officer 10,000,000 shares of common stock and warrants to purchase additional 10,000,000 shares of common stock at the exercise price of $0.0033 per share. The issuance was approved by the Company’s Compensation Committee on February 11, 2013. The warrants have a term of five years. Both shares and warrants are fully vested on the date of grant. The Company recorded $125,800 of stock-based compensation which includes $65,000 for the shares issuance and $60,800 for the warrants granted.
	On March 25, 2013, the Company issued 950,000 shares of common stock to its employees. The issuance was approved by the Board of Directors on January 7, 2013 and the shares are fully vested on the date of grant. The Company recorded $3,800 stock-based compensation in connection with such issuance.
	On March 25, 2013, the Company issued 1,250,000 shares of common stock to multiple consultants. The issuance was approved by the Board of Directors on January 7, 2013 and the shares are fully vested on the date of grant. The Company recorded $5,000 of stock-based compensation in connection with such issuance.
	On March 14, 2013 and June 25, 2013, per the terms of an agreement entered into on January 24, 2013, the Company issued total 50,000,000 shares of common stock to Engineering Technologies Group, Inc. (“ETG”). The shares were fully vested on the date of issuance. The Company recorded a stock-based compensation charge of $150,000 for the fair value of the shares included in connection with such issuance.
	On March 19, 2013, the Company issued 3,000,000 shares of common stock to a consultant for services received. The shares are fully vested on the date of issuance. The Company recorded $27,000 of consultant fees in connection with such issuance.
	On April 5, 2013, the Company issued 21,509,222 shares of common stock to an investment banker for services received. The shares are fully vested on the date of issuance. The Company recorded $80,000 of consultant fees in connection with such issuance.
	During the year ended December 31, 2012, the Company recorded the following transactions:
	Debt
	During the year ended December 31, 2012, the Company issued a total of 158,491,010 shares of common stock upon the requests from multiple convertible note holders to convert their notes plus accrued interest totaling $851,552 into the Company’s common stock based on the terms set forth in the loan. The conversion rates were from $0.0016 to $0.0443.
	In May 2011 the Company entered into an agreement and received a deposit of $130,000 for the sale of one PSWS unit. Under the terms of the agreement the Company guaranteed the customer a minimum of $37,500 of rental income under the Company’s rental pool. The Company was not able to provide the customer with delivery of the unit in a timely manner. Subsequently on July 2, 2012 the Company reached an agreement with the customer to refund the deposit of $130,000 and the $37,500 rental income by issuing 4,187,500 shares of common stock and three year warrants with an exercise price of $0.048. Accordingly the Company recorded a charge to operations for the guaranteed rental income of $37,500.
	On July 2, 2012, the Company issued 4,375,000 shares of common stock to a note lender in connection with a debt financing transaction. The Company recorded $175,000 of debt discount in connection with such issuance. The debt discount will be amortized over the term of the loan.
	In September, at the request of the lender, the Company converted $100,000 of convertible notes payable to $185,000 of notes payable. The newly issued notes payable bear interest at rates of 6% and have maturity dates in December 2012 through January 2013. The Company is required to repay the notes payable in 5 installments with the final payment of $65,000 in January 2013. As of December 31, 2012, the company repaid $45,337.11 principal which consist $20,000 cash payment and $25,337 in issuing 8,774,761 shares of common stock.
	Cash
	Through Equity Financing:
	During the year ended December 31, 2012, for gross proceeds of $412,270 the Company sold an aggregate of 51,227,383 shares of common stock and warrants to purchase additional 13,853,721 shares of common stock at exercise prices from $0.00352 to $0.072. The warrants have a term of three years and were fully vested on the grant date.
	Services
	On January 23, 2012, the Company issued 1,000,000 shares of common stock to the Company’s Chief Executive Officer per grant that was approved by the Company’s Board of Directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, the Company recorded $65,000 of stock-based compensation in connection with this issuance.
	On January 23, 2012, the Company issued 1,000,000 shares of common stock to the Company’s Chief Financial Officer per grant that was approved by the Company’s Board of Directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, the Company recorded $65,000 of stock-based compensation in connection with this issuance.
	On January 24, 2012, the Company issued an aggregate 300,000 shares of common stock to multiple employee and contractors per grant that was approved by the Company’s Board of Directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, Company recorded $19,500 of stock-based compensation in connection with this issuance.
	On February 7, 2012, the Company issued 86,538 shares of common stock as part of the retainer fee we paid to a consultant for their services rendered. The Company recorded a $4,500 consultant fee in connection with this issuance.
	On March 2, 2012, the Company issued 100,000 shares of common stock as part of the consultant fee we paid to a consultant for services rendered. The Company recorded a $6,400 marketing fee in connection with this issuance.
	On July 27, 2012, the Company issued 187,500 shares of common stock as part of the consultant fee we paid to a consultant for services rendered. The Company recorded a $7,500 marketing fee in connection with this issuance.

PREFERRED_STOCK

PREFERRED STOCK	12 Months Ended
	Dec. 31, 2013
PREFERRED STOCK	'
PREFERRED STOCK	'
	NOTE 15 – PREFERRED STOCK
	The Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.001 per share, issuable in series with rights, preferences, privileges and restrictions as determined by the Company’s board of directors.
	At December 31, 2013, outstanding preferred stock consists of the following:
		Authorized Shares	Outstanding Shares	Par Value		Current Annual Dividend Requirement		Total Dividend Arrearage		Dividend Arrearage Per Share		Liquidation Preference (Including Dividend Arrearage)
	Series A	400,000	52,500	$	52	$	52,500	$	990,100	$	17.86	$	1,515,100
	Series B	51	-		-		-		-		-		-
	Series D	2,000,000	93,000		93		55,800		975,600		9.89		1,510,350
	Series F	1,000,000	38,644		39		-		190,328		-		-
			184,144	$	184	$	108,300	$	2,156,028			$	3,025,450
	At December 31, 2012 outstanding preferred stock consists of the following:
		Authorized Shares	Outstanding Shares	Par Value		Current Annual Dividend Requirement		Total Dividend Arrearage		Dividend Arrearage Per Share		Liquidation Preference (Including Dividend Arrearage)
	Series A	400,000	52,500	$	52	$	52,500	$	937,600	$	17.86	$	1,462,600
	Series B	51	51		-		-		-		-		-
	Series D	2,000,000	93,000		93		55,800		919,800		9.89		1,454,550
	Series F	1,000,000	38,644		39		-		190,328		-		-
			184,195	$	184	$	108,300	$	2,047,728			$	2,917,150
	Series A
	The Series A preferred stock provides for a 10% cumulative dividend, based on the $10.00 per share purchase price, payable annually in common stock or cash, at the Company's option. The Series A preferred stock is not convertible, and is redeemable solely at the Company's option at a price of $11.00 per share plus accrued dividends. The Series A preferred stockholders have voting rights equal to common stockholders. In the event of the liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, holders of the Series A preferred stock are entitled to receive out of the assets of the Company the sum of $10.00 per share of Series A preferred stock then outstanding, plus a sum equal to all dividends (whether or not earned or declared) on such shares accrued and unpaid thereon to the date of final payment or distribution, before any payment or distribution upon dissolution, liquidation or winding up shall be made on any series or class of capital stock ranking junior to Series A preferred stock as to such payment or distribution.
	Series B
	On June 26, 2012 the Board of Directors of the Company designated and authorized the Series B Preferred Stock (“Series B”) as set forth in a Certificate of Designation that was filed with the Secretary of State of the State of Delaware. The Series B has a par value of $0.001 per share, no rights to dividends but provides for liquidation rights which entitle the holder to a pro-rata share of net assets. The Series B carries no conversion provisions.
	Each share of Series B Preferred has voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator entitling the holder to an aggregate 51% voting control. The Company issued 51 shares of the Series B to the Chief Executive Officer. The fair value of the shares on the date of issuance was determined to be deminimus. Subsequent to December 31, 2012 the shares were returned by the holder to the Company for no consideration and the Board of Directors approved the filing of a certificate with the State of Delaware cancelling the Series B Preferred Stock.
	Series D
	The Series D preferred stock provides for a 12% cumulative dividend, based on the $5.00 per share purchase price, payable semi-annually in common stock or cash, at the Company's option. The Series D preferred stock is not convertible, and is redeemable solely at the Company's option at a price of $5.75 per share plus accrued dividends. The Series D Preferred stockholders have voting rights equal to the common stockholders. In the event of the liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, holders of the Series D preferred stock are entitled to receive out of the assets of the Company the sum of all dividends (whether or not earned or declared) on such shares accrued and unpaid thereon to the date of final payment or distribution, before any payment or distribution upon dissolution, liquidation or winding up shall be made on any series or class of capital stock ranking junior to Series D preferred stock as to such payment or distribution.
	Series F
	The Series F 10% convertible preferred stock is a two-year convertible preferred instrument. All dividends are cumulative and are payable in shares of common stock valued at the then current market price per share, at the time of maturity, or upon conversion, whichever is earlier. The conversion rate for shares and accrued dividends payable is 40 shares of common stock for each share of preferred stock. The Series F convertible preferred stockholders have voting rights equal to the common stockholders. The Series F convertible preferred stock has no stated rights in the assets of the Company upon liquidation. In connection with Series F Preferred Stock conversions, the Company recorded dividends of $0 and $0 for each of the years ended December 31, 2013 and 2012, respectively.

STOCK_WARRANTS

STOCK WARRANTS	12 Months Ended
	Dec. 31, 2013
STOCK WARRANTS	'
STOCK WARRANTS	'
	NOTE 16 – STOCK WARRANTS
	The following warrants were issued by the Company in connection with Convertible Promissory Notes:
	The year ended December 31, 2012		1,933,333
	The year ended December 31, 2013		32,283,332
	The following warrants were issued by the Company in connection with various employment and compensation agreements:
	The year ended December 31, 2012		43,746,410
	The year ended December 31, 2013		71,786,055
	The following warrants were issued by the Company in connection with equity private placements:
	The year ended December 31, 2012		13,853,721
	The year ended December 31, 2013		-
	The following warrants were exercised:
	The year ended December 31, 2012		-
	The year ended December 31, 2013		10,707,030
	The following warrants were expired:
	The year ended December 31, 2012		1,402,058
	The year ended December 31, 2013		2,440,424
	The following tables sets forth information concerning the Company's warrant issuances and warrant balances outstanding as of, and during the years ended December 31, 2013 and 2012:
		Shares Underlying Warrants		Weighted Average Exercise Price			Intrinsic
	Value
	Outstanding at December 31, 2011	27,520,997		$	0.06		$	-
	Granted	59,533,464			0.01			-
	Expired	-1,402,058			0.05			-
	Exercised	-			-			-
	Outstanding at December 31, 2012	85,652,403		$	0.03		$	-
	Granted	104,069,387			0.006			-
	Expired	-2,440,474			0.09			-
	Exercised	-10,707,030			0.006			-
	Outstanding at December 31, 2013	176,574,286			0.02			-
	The following is additional information with respect to the Company's warrants as of December 31, 2013:
	Number of Warrants	Range of Exercise Price		Weighted Average Remaining Contractual Life (In Years)		Average Exercise Price			Currently Exercisable
	129,078,495	$0.003-$0.0096		3.76		$	0.0051		129,078,495
	44,308,863	$0.0108-$0.0964		1.34		$	0.0362		44,308,863
	3,127,404	$0.1-$0.1884		2.62		$	0.1173		3,127,404
	59,524	$0.84		1.91		$	0.84		59,524
	176,574,286								176,574,286

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
INCOME TAXES	'
INCOME TAXES	'
	NOTE 17 – INCOME TAXES
	The income tax provision (benefit) consists of the following:
		December 31,
		2013			2012
	Federal
	Current		-			-
	Deferred		5,739,800			-1,009,700
	State and local
	Current		-			-
	Deferred		961,500			-260,300
	Change in valuation allowance		-6,701,300			1,270,000
	Income tax provision (benefit)		-			-
	The reconciliation between the statutory federal income tax rate (34%) and the Company’s effective rate for the year ended December 31, 2013 and 2012 is as follows:
		2013		2012
	U.S. Federal statutory rate	-34.00%		-34.00%
	State tax benefit, net of federal tax	-5.7		-5.7
	Sec 382 impairment of NOL carryover	258.2		-
	Other permanent differences	1.8		1.5
	Deferred tax true-up	-13.3		-7.8
	Change in valuation allowance	-207		46
	Income tax provision (Benefit)	0.00%		0.00%
	As of December 31, 2013 and 2012 the deferred tax asset consisted of the following:
		2013			2012
	Deferred Tax Asset
	Net operating loss carryovers	$	3,705,200		$	10,939,700
	Stock-based compensation		1,455,700			1,230,500
	Derivative liability		82,000			32,000
	Fixed asset depreciation		-			57,800
	Contributions carryover		3,100			100
	Accrued legal claims		173,000			-
	Accrued compensation		503,100			309,100
	Deferred rent		-			2,800
	Total deferred tax asset		5,922,100			12,572,000
	Valuation allowance		-5,838,700			-12,540,000
	Net Deferred Tax Asset, net of valuation allowance		83,400			32,000
	Deferred Tax Liability
	Convertible debt		-83,400			32,000
	Total deferred tax liability		-83,400			32,000
	Net Deferred Tax Asset (Liability)	$	-		$	-
	As of December 31, 2013 and 2012, the Company had approximately $9.3 million and $23.4 million, respectively, of U.S. federal and state net operating loss carryovers available to offset future taxable income. These net operating losses which, if not utilized, begin expiring between the years 2013 through 2033. In accordance with Section 382 of the Internal Revenue Code, deductibility of the Company’s net operating loss carry over may be subject to an annual limitation in the event of a change of control.  The Company performed an evaluation as to whether a change of control, as defined under the regulations has taken place, and concluded that a change of control has occurred during the period ended December 31, 2013. Due to the section 382 ownership change the Company’s Nol carryovers are subject to an annual limitation of approximately $467,000. The Company’s deferred tax asset related to its net operating loss carryovers has been impaired by $8,358,000 since this represents the tax effect of the Company’s net operating loss carryovers that will expire unused due to the annual limitation as calculated under section 382.
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. ASC 740 - “Income Taxes” requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. A review of all available positive and negative evidence needs to be considered, including the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies. Management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance as of December 31, 2013 and December 31, 2012. For the year ended December 31, 2013 and 2012 the change in deferred tax asset valuation allowance was $(6,701,300) and $1,270,000 respectively.
	Management evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits." A liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise's potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.
	Interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as "Interest expense, net" in the statements of operation. Penalties would be recognized as a component of "General and administrative expenses."
	No interest or penalties were recorded during the years ended December 31, 2013 and December 31, 2012 respectively. As of December 31, 2013 and December 31, 2012 no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year.
	The Company files tax returns in U.S. federal and various state jurisdictions and is subject to audit by tax authorities beginning with the year ended December 31, 2010.

SUBSCRIPTIONS_RECEIVABLE

SUBSCRIPTIONS RECEIVABLE	12 Months Ended
	Dec. 31, 2013
SUBSCRIPTIONS RECEIVABLE	'
SUBSCRIPTIONS RECEIVABLE	'
	NOTE 18 – SUBSCRIPTIONS RECEIVABLE
	In April 2008, a consultant for the Company, entered into Stock Purchase, Loan and Security Agreements with the Company. Under the agreements, the Company loaned the individual $337,200. The obligations to repay the loans were evidenced by non-recourse promissory note. The note called for interest at a rate of 6% per annum and matured on April 16, 2011, at which time there was a three year extension granted. The loaned funds were to be used exclusively for the purchase of 4 million shares of the Company’s Common Stock. The stock is being held as collateral for the repayment of the loan. The purchase price of the stock was based on the average closing price of the Common Stock during the 30 trading days immediately preceding the date of the April 2008 agreements which equaled $0.0843. During the fourth quarter of 2013 the subscription receivable along with accrued interest in the aggregate amount of $446,156 was written off.

CREDIT_RISK

CREDIT RISK	12 Months Ended
	Dec. 31, 2013
CREDIT RISK	'
CREDIT RISK	'
	NOTE 19 – CREDIT RISK
	The Company maintains its checking and money market accounts in banks. Accounts at each bank are insured by the Federal Deposit Insurance Corporation (“FDIC”). At times, cash and cash equivalents may be uninsured or in deposit accounts that exceed the FDIC insurance limit.
	Periodically, the Company evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2013
SUBSEQUENT EVENTS	'
SUBSEQUENT EVENTS	'
	NOTE 20 – SUBSEQUENT EVENTS
	On December 31, 2013 Gerard Stoehr’s contract as Chief Operating Officer expired and was not renewed by the Company. The Company owes Mr. Stoehr $60,000 which has been accrued for as of December 31, 2013.
	Terry R. Lazar, Chief Financial Officer of the Company and a Director resigned on February 14, 2014 as Chief Financial Officer and from the Company’s Board of Directors.
	Effective March 7, 2014, Theresa Bischoff resigned as a Director of the Company.
	Effective March 7, 2014 Dr. Stephen E. Flynn resigned as a Director of the Company.
	On April 2, 2014, the Company Board of Directors elected Stephen M. Hicks to the Board of Directors, to fill a vacancy on the Board, and as President of the Company. Mr. Hicks is the Chief Executive Officer of Southridge LLC (“Southridge.”) Southridge and its affiliates have financed the Company in the past and continue to own debt and equity securities of the Company. New directors, who are not officers, are paid $12,500 per year in cash or stock.
	On April 2, 2014, the Company Board of Directors elected Mr. Gilbert Steedley to the Board to fill a vacancy on the Board. Mr. Steedley is currently interim Chief Executive Officer and Director of Accelpath, New York, N.Y. Compensation is as indicated above for Mr. Hicks.
	On April 2, 2014, the Company elected Henry Sargent as Vice President and Secretary of the Company. Mr. Sargent is Chief Operating Officer and General Counsel of Southridge.
	Issuance of Common Stock
	From January 1, 2014 until October 23, 2014, the Company converted a total of $219,620 loan principal plus $24,850 accrued interest and fees into 414,812,709 shares of common stock.
	On March 13, 2014, a warrant holder exercised 625,000 warrants at exercise price of $0.0025. The holder elected their cash-less exercise provision. Accordingly, the Company issued 526,315 shares of common stock in connection with such exercise.
	On August 27, 2013 the Company received proceeds of $10,500 for the exercise of 1,093,750 warrants and as of December 31, 2013 the shares had not been issued and accordingly the Company recorded the liability for the share issuance. On August 19, 2014, due to the decline in market price of our stock, the Company issued the warrant holder 9,545,455 shares.
	On July 9, 2013 the Company received proceeds of $27,923 for the exercise of 2,389,817 warrants and as of December 31, 2013 the shares had not been issued and accordingly the Company recorded the liability for the share issuance. On August 19, 2014, due to the decline in market price of our stock, the Company issued the warrant holder 27,202,727 shares.
	On January 8, 2014, the Company issued 13,265,625 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $47,756 of interest expense for such issuance.
	On July 1, 2014, the Company issued 7,634,921 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $12,979 of interest expense for such issuance.
	On September 15, 2014, the Company issued 7,027,778 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $4,919 of interest expense for such issuance.
	Issuance of Promissory Notes
	On January 15, 2014 a Promissory Note was issued to a lender in the amount of $ 15,000. The Note bears no interest and matures on January 15, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On January 23, 2014 a Promissory Note was issued to a lender in the amount of $ 15,000. The Note bears no interest and matures on January 23, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On January 23, 2014 a Promissory Note was issued to a lender in the amount of $ 15,000. The Note bears no interest and matures on January 23, 2015. A UCC was issued on the system operating at the Landfill as security for the Note.
	On February 4, 2014 a Promissory Note was issued to a lender in the amount of $ 15,000. The Note bears no interest and matures on February 4, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On February 20, 2014 a Promissory Note was issued to a lender in the amount of $ 15,000. The Note bears no interest and matures on February 20, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On February 20, 2014 a Promissory Note was issued to a lender in the amount of $ 7,500. The Note bears no interest and matures on February 20, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On February 20, 2014 a Promissory Note was issued to a lender in the amount of $ 7,500. The Note bears no interest and matures on February 20, 2015. A UCC financing statement was filed on the system operating at the Landfill as security for the Note.
	On April 25, 2014 the Company issued a promissory note for $ 100,000. The note matures on April 30, 2015 with the stated interest rate at 8%.
	Issuance of Convertible Promissory Notes
	On April 4, 2014 the Company issued a convertible promissory note for $ 50,000 to a related party. The note matures in one year from the issuance date with the stated interest rate at 0%. The note is convertible into the Company’s common stock at a 40% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	On April 21, 2014 the Company issued a convertible promissory note to a related party for $2,500. The note matures on April 30, 2015 with the stated interest rate at 0%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	On June 19, 2014 the Company issued a convertible promissory note for $ 100,000. The note matures on December 31, 2014 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0019 per share. In addition, 10,526,316 warrants were issued with an exercise price of $0.00228 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On July 17, 2014 the Company issued a convertible promissory note for $ 23,000. The note matures on June 30, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.001 per share. In addition, 4,600,000 warrants were issued with an exercise price of $0.0012 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On July 17, 2014 the Company issued a convertible promissory note for $ 20,000. The note matures on December 31, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 10 trading days prior to conversion.
	On August 13, 2014 the Company issued a convertible promissory note for $ 85,000. The note matures on June 30, 2015 with the stated interest rate at 8%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 20 trading days prior to conversion.
	On September 16, 2014 the Company issued a convertible promissory note for $ 23,000. The note matures on June 30, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0005 per share. In addition, 9,200,000 warrants were issued with an exercise price of $0.0006 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	Entry Into A Material Definitive Agreement
	On June 13, 2014, the Company entered into a consulting agreement (the “Consulting Agreement”) with Tarpon Bay Partners, LLC, a Florida limited liability company (“Tarpon”), for the period from the date of the agreement through March 31, 2015. The agreement requires Tarpon to provide general management and consulting services and advisory services to the Company, including assistance in connection with the restructuring of its outstanding debt and equity securities. The manager of Tarpon is Stephen Hicks, the President of the Company.
	Pursuant to the terms of the Consulting Agreement, Tarpon will be compensated by the issuance to it by the Company of shares of Series H Convertible Preferred Stock. Pursuant to the terms of the Consulting Agreement, Tarpon will receive Series H Preferred Stock with a stated value of $425,000 upon the execution of the Agreement, and additional Series H Preferred Stock with a stated value of $75,000 monthly, commencing July 1, 2014 and continuing through the balance of the term. The execution and delivery of the Consulting Agreement was approved by the directors of the Company. Mr. Hicks did not participate in the vote on this matter.
	On June 13, 2014, the Company entered into an Equity Purchase Agreement with an accredited investor. The terms of the Equity Purchase Agreement provide that the Investor agrees, subject to put notices from the Company, to purchase up to $5,000,000 in Common Stock during the 24 months following the execution of the Agreement, subject to certain conditions and limitations. For each closing, the purchase price of the Common Stock will be 90% of the average of the three lowest Closing Bid Prices during the 10 trading days following the relevant Clearing Date (as defined in the Equity Purchase Agreement). In connection therewith, the Company also entered into a Registration Rights Agreement with the investor, pursuant to which the Company is required to file a Registration Statement with the Securities and Exchange Commission for the expected number of shares to be issued under the Equity Purchase Agreement within 120 days of the date of the Registration Rights Agreement. The Investor also provided the Company with a one year loan of $100,000; the obligation to repay this loan is represented by a Promissory Note issued by the Company to the Investor.
	Series A and Series F Preferred Stock
	On June 3, 2014, the Company filed with the Secretary of State of the State of Delaware Certificates of Correction to its existing Certificates of Designations for its Series A and Series F Preferred Stock, respectively. These filings reduced the number of authorized shares of the Company’s Series A Preferred Stock from the previously reported 400,000 shares to 52,500 shares and the number of authorized shares of the Series F Preferred Stock from the previously reported 1,000,000 shares to 38,644 shares. In each case, the current number of outstanding shares (as of the date of filing of each Certificate of Correction, 2014) of the relevant Series is not more than the number of authorized shares specified in the corresponding Certificate of Correction.
	Series G Preferred Stock
	On June 13, 2014, the number, designation, rights, preferences and privileges of the Series G Preferred Stock were established by the Board. The designation, rights, preferences and privileges that the Board established for the Series G Preferred Stock are set forth in a Certificate of Designations that was filed with the Secretary of State of the State of Delaware on June 17, 2014. Among other things, the Certificate of Designation provides that each one share of Series G Preferred has voting rights equal to (x) (i) 0.019607 multiplied by the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the number determined by this clause (i), the “Numerator”), divided by (ii) 0.49, minus (y) the Numerator. These voting rights apply only to matters of Company capitalization (i.e. increase in authorized common stock, stock splits, etc.), and similar matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent. The Series G has a par value of $0.001 per share, no rights to dividends but provides for liquidation rights which entitle the holder to a pro-rata share of net assets. Each Series G share is convertible, at the option of the holder, into one share of Common Stock. The Company issued 51 shares of the Series G to the President.
	Material Modification to Rights of Security Holders
	By unanimous written consent of the Board (Mr. Hicks not participating), the Board authorized the filing of a Certificate of Designation for its Series G Convertible Preferred Stock (“Series G Preferred Stock”) and the issuance of all of the fifty-one (51) authorized shares of such Series G Preferred Stock to Stephen Hicks (the “Series G Stockholder”) for a purchase price of $1 per share. As a result of the voting rights granted to the Series G Preferred Stock in the Certificate of Designations, the Series G Stockholder holds in the aggregate approximately 51% of the total voting power of all issued and outstanding voting capital of the Company. Pursuant to the terms of the Board resolution authorizing the issuance of the Series G Preferred Stock, and authorizing the issuance of the shares to Mr. Hicks, the Company has the right to redeem said Preferred Stock of the Company upon his resignation or the termination of his services as President of the Company. The Company believes that the issuance of the Series G Preferred Stock to Mr. Hicks will facilitate the Company’s ability to manage its affairs.
	Series H Preferred Stock
	On June 13, 2014, the number, designation, rights, preferences and privileges of the Series H Preferred Stock were established by the Board. The designation, rights, preferences and privileges that the Board established for the Series H Preferred Stock are set forth in a Certificate of Designations that was filed with the Secretary of State of the State of Delaware on June 17, 2014.
	The Certificate of Designations for the Series H Preferred Stock provides for the issuance of up to 1,000 shares of Series H stock with a stated value of $25,000 per share. As long as any shares of Series H Preferred Stock remain outstanding, the Company cannot, without the consent of the holders of at least 90% of the Series H Preferred Stock, redeem, repurchase or otherwise acquire any junior securities, or pay or make any distribution upon any junior securities as defined therein.
	The Series H Preferred Stock is convertible at the option of the holder into such number of shares upon the conversion ratio equal to the aggregate stated value of the Series H Preferred Stock converted divided by the average closing bid price for the calendar month preceding the original issuance date of the shares being converted, as reported by the reporting service. The Company is required to reserve a sufficient number of shares of common stock as may be required to be issued thereunder. The conversion ratio is subject to adjustment, from time to time, for various reasons including a sale or merger by the Company.
	With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series H Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or bylaws.
	On September 30, 2014 the Company entered into an agreement in-order to satisfy an outstanding liability of the Company to our former Vice President of International Markets, Shaul Kochan, dating back to 2009. Per the terms of the agreement the Company shall issue 110 shares of preferred stock with a stated value equal to $110,000. The Company has agreed to redeem the preferred stock in 14 separate tranches at the beginning of each calendar month beginning October 1, 2014, pursuant to the following schedule: $5,000 in stated value worth of shares each month for the first 4 months; $7,500 in stated value worth of shares each month for the subsequent 6 tranches; $10,000 in stated value worth of shares each month for the subsequent 3 tranches; and $15,000 in stated value worth of shares in the final month.
	If the Company misses payment of any tranche it will have 30 calendar days in which to cure such payment, after which time the Company agrees to issue additional shares of preferred stock representing 1% of the aggregate stated value of the then outstanding preferred stock held by Mr. Kochan, redeemable under similar terms.
	In addition, the Company agrees to extend the maturity date of the outstanding warrant held by Mr. Kochan from its current expiration date of March 7, 2015 to March 7, 2017. The Company further agrees to issue an additional warrant to Mr. Kochan for right to exercise and purchase 2,000,000 shares of the Company’s common stock at an exercise price of $0.052 and maturity date of March 7, 2017.

ACCOUNTING_POLICIES_POLICIES

ACCOUNTING POLICIES (POLICIES)	12 Months Ended
	Dec. 31, 2013
ACCOUNTING POLICIES	'
Basis of Presentation	'
	Basis of Presentation
	The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Principles of Consolidation	'
	Principles of Consolidation
	The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.
	The Company's consolidated subsidiaries and/or entities are as follows:
	Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation(date of acquisition, if applicable)	Attributable interest
	PureSafe Manufacturing and Research Corporation	Delaware	29-Sep-09	100%
	The consolidated financial statements include all accounts of the Company and consolidated subsidiaries and/or entities as of December 31, 2013 and 2012 and for the years then ended.
	All inter-company balances and transactions have been eliminated.
Use of Estimates	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The most significant estimates, among other things, are used in accounting for allowances for deferred income taxes, expected realizable values for long-lived assets (primarily intangible assets and property and equipment), contingencies, as well as the recording and presentation of its common stock and other securities. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the consolidated financial statements in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2013 and 2012 the Company did not have any cash equivalents.
Patents and Trademarks	'
	Patents and Trademarks
	Patents and trademarks amortize ratably over nine to fourteen years. The Company assesses the carrying value of its patents for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the years ended December 31, 2013 and 2012.
Property and Equipment	'
	Property and Equipment
	Property and equipment consists primarily of equipment and furniture and fixtures and is stated at cost. Depreciation and amortization are provided using the straight line method over the estimated useful lives (generally three to seven years) of the related assets. Leasehold improvements, once placed in service, are amortized over the shorter of the useful life or the remainder of the lease term. Expenditures for maintenance and repairs, which do not extent the economic useful life of the related assets, are charged to operations are incurred. Gains or losses on disposal of property and equipment are reflected in the statement of operations in the period of disposal.
Revenue Recognition	'
	Revenue Recognition
	The Company generally recognizes revenues under Staff Accounting Bulletin No. 104 when the following criteria are met, persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller's price to the buyer is fixed or determinable, and collectibility is reasonably assured. In addition the Company may enter into agreements that include multiple elements (i.e., products and services/training). Revenue under multiple element arrangements is recognized in accordance with FASB ASC 605-25 Multiple-Element Arrangements (“ASC 605”). When vendor specific objective evidence or third party evidence of selling price for deliverables in an arrangement cannot be determined, the Company develops a best estimate of the selling price to separate deliverables and allocates arrangement consideration using the relative selling price method. Additionally, this guidance eliminates the residual method of allocation. If an arrangement includes undelivered elements that are not essential to the functionality of the delivered elements, we defer the fair value of the undelivered elements with the residual revenue allocated to the delivered elements. Fair value is determined based upon the price charged when the element is sold separately. If there is not sufficient evidence of the fair value of the undelivered elements, no revenue is allocated to the delivered elements and the total consideration received is deferred until delivery of those elements for which objective and reliable evidence of the fair value is not available. For the years ended December 31, 2013 and 2012, the Company did not have any multiple deliverable elements.
Inventories	'
	Inventories
	Inventory consisting primarily of finished goods and raw materials is stated at the lower of cost or market utilizing the first-in, first-out method. The Company continually analyzes its slow-moving, excess and obsolete inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves. If the Company does not meet its sales expectations, these reserves are increased. Products that are determined to be obsolete are written down to net realizable value. As of December 31, 2013, the inventory has been written down to its net realizable value.
Deferred Financing Costs	'
	Deferred Financing Costs
	Cost incurred in conjunction with the debt financing has been capitalized and will be amortized to interest expense using the straight line method, which approximates the interest rate method over the term of the debt and is included as a component of other assets. Amortization of deferred financing cost was approximately $25,000 and $125,000 for the years ended December 31, 2013 and 2012, respectively.
Derivative Liabilities	'
	Derivative Liabilities
	In connection with the issuance of certain convertible promissory notes, the terms of the convertible notes included an embedded conversion feature; which provided for the settlement of certain convertible promissory notes into shares of common stock at a rate which was determined to be variable. The Company determined that the conversion feature was an embedded derivative instrument pursuant to ASC 815 “Derivatives and Hedging”
	The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible promissory notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.
	The fair value of conversion options that are convertible at a fixed number of shares or at a fixed conversion price are recorded using the intrinsic value method and conversion options at variable rates are valued using a Black-Scholes Valuation Model. Variable conversion options are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815. Since, “down-round protection” is not an input into the calculation of the fair value of the conversion option and cannot be considered “indexed to the Company’s own stock” which is a requirement for the scope exception as outlined under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Black-Scholes Valuation Model to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model. The Company’s outstanding warrants did not contain any down round protection.
	The Black-Scholes Valuation Model is used to estimate the fair value of the warrants and conversion option. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the instrument granted.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.10 - 1.75%	0.37 - 1.18%
	Expected life	3 - 5 years	1 month - 6 years
	Expected volatility	125% - 175%	108%-171%
	Dividends	0.00%	0.00%
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company reports stock-based compensation under Accounting Standard Codification (“ASC”) 718 “Compensation – Stock Compensation”. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.
	The Company accounts for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.
	For the years ended December 31, 2013 and 2012 the Company recorded stock based compensation of $731,200 and $505,600, respectively.
	The Black-Scholes option valuation model is used to estimate the fair values of options. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the subject options or warrants.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.3 - 1.6%	0.36%
	Expected life	3 to 5 years	3 years
	Expected volatility	125% - 175%	117%
	Dividends	0.00%	0%
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company’s financial instruments consist principally of cash, accounts payable and accrued expenses and debt payable. The Company determines the estimated fair value of such financial instruments presented in these financial statements using available market information and appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate fair value due to their short term nature.
Advertising and Marketing	'
	Advertising and Marketing
	Advertising and marketing costs are expensed as incurred and are included in selling, general and administrative expenses. The Company incurred a charge of approximately $25,835 and $213,553 for the years ended December 31, 2013 and 2012, respectively.
Income Taxes	'
	Income Taxes
	Income taxes are accounted for under ASC 740, "Income Taxes," which is an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and net operating loss and tax credit carryovers. Valuation allowances are established when necessary to reduce deferred tax assets to amounts more likely than not to be realized.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	The Company assesses the recoverability of its long lived assets, including property and equipment when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company first compares the carrying amount of the asset to the asset’s estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the asset’s estimated future cash flows (discounted and with interest charges). If the carrying amount exceeds the asset’s estimated futures cash flows (discounted and with interest charges), the loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets. Based on its assessments, the Company did not incur any impairment charges for the years ended December 31, 2013 and 2012.
Research and Development	'
	Research and Development
	Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge, which will be useful in developing new products or processes. The Company expenses all research and development costs as incurred. The Company incurred a charge of approximately $55,874 and $62,032 for the years ended December 31, 2013 and 2012, respectively.
Subsequent Events	'
	Subsequent Events
	The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would require adjustment or disclosure in the consolidated financial statements.

Principal_assumptions_used_in_

Principal assumptions used in applying the Black-Scholes model (Tables)	12 Months Ended
	Dec. 31, 2013
Principal assumptions used in applying the Black-Scholes model	'
Principal assumptions used in applying the Black-Scholes model	'
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.10 - 1.75%	0.37 - 1.18%
	Expected life	3 - 5 years	1 month - 6 years
	Expected volatility	125% - 175%	108%-171%
	Dividends	0.00%	0.00%
Schedule of Assumptions Used applying the Black-Scholes model were as follows	'
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Years Ended
		December 31,
		2013	2012
	Assumptions:
	Risk-free interest rate	0.3 - 1.6%	0.36%
	Expected life	3 to 5 years	3 years
	Expected volatility	125% - 175%	117%
	Dividends	0.00%	0%

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE PROPERTY AND EQUIPMENT	'
SCHEDULE PROPERTY AND EQUIPMENT	'
	Property and equipment consist of the following at December 31, 2013 and 2012:
		2013		2012
	Leasehold improvement	$	74,945	$	74,945
	Furniture and fixtures		31,987		49,265
	Equipment		72,358		89,514
			179,290		213,724
	Accumulated depreciation and amortization		-179,290		-164,710
	Property and equipment, net	$	-	$	49,014

SCHEDULE_OF_PATENTS_AND_TRADEM

SCHEDULE OF PATENTS AND TRADEMARKS (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF PATENTS AND TRADEMARKS	'
SCHEDULE OF PATENTS AND TRADEMARKS	'
	Patents and trademarks as of December 31, 2013 and 2012 consist of the following:
		2013		2012
	Patents	$	104,621	$	97,164
	Trademarks		2,720		2,720
	Total cost		107,341		99,884
	Accumulated amortization		-47,919		-41,816
	Patents and trademarks, net	$	59,422	$	58,068
Schedule of estimate for amortization expense Table	'
	The following table presents the Company's estimate for amortization expense for each of the five succeeding years and thereafter.
	Year Ended December 31,
	2014	$	6,100
	2015		6,100
	2016		6,100
	2017		6,100
	2018		6,100
	2019 and thereafter		28,922
		$	59,422

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF INVENTORIES	'
Schedule of Inventory, Current	'
	Inventories consist of the following at December 31, 2013 and 2012,
			2013		2012
	Raw materials	$	-	$	43,684
	Finished Goods		141,636		279,034
	Total	$	141,636	$	322,718

NET_LOSS_PER_SHARE_OF_COMMON_S1

NET LOSS PER SHARE OF COMMON STOCK (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF NET LOSS PER SHARE OF COMMON STOCK	'
SCHEDULE OF NET LOSS PER SHARE OF COMMON STOCK	'
	Total shares issuable upon the exercise of warrants and conversion of preferred stock and convertible promissory notes for the years ended December 31, 2013 and 2012 were as follows:
		December 31,
		2013	2012
	Warrants	176,574,286	85,652,403
	Convertible promissory notes	492,877,340	187,297,345
	Convertible preferred stock	1,545,760	1,545,760
	Total	670,997,386	274,495,508

Schedule_Of_Assets_and_Liabili

Schedule Of Assets and Liabilities Measured at Fair Value (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule Of Assets and Liabilities Measured at Fair Value	'
Schedule of Fair Value, Liabilities Measured on Recurring Basis	'
	Liabilities measured at fair value on a recurring basis at December 31, 2013 and 2012 are as follows:
		Quoted Prices in Active Markets for Identical Liabilities		Significant Other Observable Inputs		Significant Unobservable Inputs		Balance at
		(Level 1)		(Level 2)		(Level 3)		December 31,
	Embedded conversion feature	$	–	$	–	$	224,000	$	224,000
	Warrant liability	$	–	$	–	$	39,300	$	39,300
	Balance at December 31, 2012	$	–	$	–	$	263,300	$	263,300
	Embedded conversion feature	$	–	$	–	$	206,500	$	206,500
	Warrant liability	$	–	$	–	$	92,500	$	92,500
	Balance at December 31, 2013	$	–	$	–	$	299,000	$	299,000
Fair Value, Assets Measured on Recurring Basis, Unobservable Input	'
	The following table provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets measured at fair value on a recurring basis using significant unobservable inputs during the year ended December 31, 2013 and 2012.
		Warrants		Conversion		Total
				Feature
	Balance at - January 1, 2012	$	446,400	$	68,800	$	515,200
	Change in fair value of derivative liability		-537,500		-460,800		-998,300
	Included in liabilities (debt discount)		28,100		621,000		649,100
	Included in stock based compensation		17,200		–		17,200
	Included in stockholder’s equity		85,100		-5,000		80,100
	Balance at - December 31, 2012	$	39,300	$	224,000	$	263,300
	Included in stock based compensation		4,500		–		4,500
	Change in fair value of derivative liability		-297,100		-95,900		-393,000
	Included in liabilities (debt discount)		114,000		240,000		354,000
	Included in liabilities (derivative expense)		209,800		35,400		245,200
	Included in stockholder's equity		22,000		-197,000		-175,000
	Transfers in and /or out of Level 3		–		–		–
	Balance at - December 31, 2013	$	92,500	$	206,500	$	299,000

Schedule_of_Notes_payable_and_

Schedule of Notes payable and accrued interest (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Notes payable and accrued interest Table Text Block:	'
Schedule of Notes payable and accrued interest Table Text Block	'
	Notes payable and accrued interest at December 31, 2013 and 2012 consist of the following:
		December 31,
		2013			2012
		$	-	(a)	$	15,221	(a)
			75,000	(b)		75,000	(b)
			245,860	(c)		237,006	(c)
			175,841	(d)		165,628	(d)
			83,952	(e)		222,170	(e)
			-	(f)		-	(f)
			12,500	(g)		-	(g)
	Notes payable and accrued interest		593,153			715,025
	Less: Current maturities		-593,153			-706,829
	Notes payable and accrued interest, net of Current maturities	$	-		$	8,196

CONVERTIBLE_PROMISSORY_NOTES_P1

CONVERTIBLE PROMISSORY NOTES PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF CONVERTIBLE PROMISSORY NOTES PAYABLE	'
SCHEDULE OF CONVERTIBLE PROMISSORY NOTES PAYABLE	'
	Convertible promissory notes payable and accrued interest at December 31, 2013 and 2012 consists of the following:
		December 31,
		2013		2012
	Convertible notes payable	$	1,449,619	$	1,191,716
	Discount on convertible notes		-210,781		-80,606
	Convertible notes payable, net		1,238,838		1,111,110
	Less current maturities		-1,238,838		-1,111,110
	Long-Term Portion	$	-	$	-

CONVERTIBLE_NOTES_AND_NOTES_PA1

CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	'
SCHEDULE OF CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	'
	Convertible notes and notes payable – Officers & Director and accrued interest at December 31, 2013 and 2012 consists of the following:
		2013			2012
		$	435,382	(a)	$	406,682	(a)
			222,322	(b)		208,322	(b)
			54,008	(c)		57,260	(c)
			39,113	(d)		71,490	(d)
			46,378	(e)		42,378	(e)
			25,000	(f)		25,000	(f)
			5,051	(g)		-	(g)
	Total		827,254			811,132
	Less: Current maturities		-827,254			-811,132
	Convertible notes and notes payable – Officers & Director and accrued interest, net of Current maturities	$	-		$	-

PREFERRED_STOCK_Tables

PREFERRED STOCK (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of outstanding preferred stock consists of the following	'
Schedule of outstanding preferred stock consists of the following	'
	At December 31, 2013, outstanding preferred stock consists of the following:
		Authorized Shares	Outstanding Shares	Par Value		Current Annual Dividend Requirement		Total Dividend Arrearage		Dividend Arrearage Per Share		Liquidation Preference (Including Dividend Arrearage)
	Series A	400,000	52,500	$	52	$	52,500	$	990,100	$	17.86	$	1,515,100
	Series B	51	-		-		-		-		-		-
	Series D	2,000,000	93,000		93		55,800		975,600		9.89		1,510,350
	Series F	1,000,000	38,644		39		-		190,328		-		-
			184,144	$	184	$	108,300	$	2,156,028			$	3,025,450
	At December 31, 2012 outstanding preferred stock consists of the following:
		Authorized Shares	Outstanding Shares	Par Value		Current Annual Dividend Requirement		Total Dividend Arrearage		Dividend Arrearage Per Share		Liquidation Preference (Including Dividend Arrearage)
	Series A	400,000	52,500	$	52	$	52,500	$	937,600	$	17.86	$	1,462,600
	Series B	51	51		-		-		-		-		-
	Series D	2,000,000	93,000		93		55,800		919,800		9.89		1,454,550
	Series F	1,000,000	38,644		39		-		190,328		-		-
			184,195	$	184	$	108,300	$	2,047,728			$	2,917,150

SCHEDULE_OF_STOCK_WARRANTS_Tab

SCHEDULE OF STOCK WARRANTS (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF STOCK WARRANTS TABLES	'
SCHEDULE OF STOCK WARRANTS ISSUED	'
	The following warrants were issued by the Company in connection with Convertible Promissory Notes:
	The year ended December 31, 2012		1,933,333
	The year ended December 31, 2013		32,283,332
	The following warrants were issued by the Company in connection with various employment and compensation agreements:
	The year ended December 31, 2012		43,746,410
	The year ended December 31, 2013		71,786,055
	The following warrants were issued by the Company in connection with equity private placements:
	The year ended December 31, 2012		13,853,721
	The year ended December 31, 2013		-
	The following warrants were exercised:
	The year ended December 31, 2012		-
	The year ended December 31, 2013		10,707,030
	The following warrants were expired:
	The year ended December 31, 2012		1,402,058
	The year ended December 31, 2013		2,440,424
Schedule of warrant issuances and warrant balances outstanding	'
	The following tables sets forth information concerning the Company's warrant issuances and warrant balances outstanding as of, and during the years ended December 31, 2013 and 2012:
		Shares Underlying Warrants		Weighted Average Exercise Price			Intrinsic
	Value
	Outstanding at December 31, 2011	27,520,997		$	0.06		$	-
	Granted	59,533,464			0.01			-
	Expired	-1,402,058			0.05			-
	Exercised	-			-			-
	Outstanding at December 31, 2012	85,652,403		$	0.03		$	-
	Granted	104,069,387			0.006			-
	Expired	-2,440,474			0.09			-
	Exercised	-10,707,030			0.006			-
	Outstanding at December 31, 2013	176,574,286			0.02			-
Additional information with respect to the Company's warrants Table	'
	The following is additional information with respect to the Company's warrants as of December 31, 2013:
	Number of Warrants	Range of Exercise Price		Weighted Average Remaining Contractual Life (In Years)		Average Exercise Price			Currently Exercisable
	129,078,495	$0.003-$0.0096		3.76		$	0.0051		129,078,495
	44,308,863	$0.0108-$0.0964		1.34		$	0.0362		44,308,863
	3,127,404	$0.1-$0.1884		2.62		$	0.1173		3,127,404
	59,524	$0.84		1.91		$	0.84		59,524
	176,574,286								176,574,286

SCHEDULE_OF_COMPONENTS_OF_INCO

SCHEDULE OF COMPONENTS OF INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2013
SCHEDULE OF COMPONENTS OF INCOME TAXES Tables	'
Schedule of Components of Income Tax Expense (Benefit)	'
	The income tax provision (benefit) consists of the following:
		December 31,
		2013			2012
	Federal
	Current		-			-
	Deferred		5,739,800			-1,009,700
	State and local
	Current		-			-
	Deferred		961,500			-260,300
	Change in valuation allowance		-6,701,300			1,270,000
	Income tax provision (benefit)		-			-
Effective Income Tax Rate Reconciliation	'
	The reconciliation between the statutory federal income tax rate (34%) and the Company’s effective rate for the year ended December 31, 2013 and 2012 is as follows:
		2013		2012
	U.S. Federal statutory rate	-34.00%		-34.00%
	State tax benefit, net of federal tax	-5.7		-5.7
	Sec 382 impairment of NOL carryover	258.2		-
	Other permanent differences	1.8		1.5
	Deferred tax true-up	-13.3		-7.8
	Change in valuation allowance	-207		46
	Income tax provision (Benefit)	0.00%		0.00%
Deferred Tax Assets and Liabilities	'
	As of December 31, 2013 and 2012 the deferred tax asset consisted of the following:
		2013			2012
	Deferred Tax Asset
	Net operating loss carryovers	$	3,705,200		$	10,939,700
	Stock-based compensation		1,455,700			1,230,500
	Derivative liability		82,000			32,000
	Fixed asset depreciation		-			57,800
	Contributions carryover		3,100			100
	Accrued legal claims		173,000			-
	Accrued compensation		503,100			309,100
	Deferred rent		-			2,800
	Total deferred tax asset		5,922,100			12,572,000
	Valuation allowance		-5,838,700			-12,540,000
	Net Deferred Tax Asset, net of valuation allowance		83,400			32,000
	Deferred Tax Liability
	Convertible debt		-83,400			32,000
	Total deferred tax liability		-83,400			32,000
	Net Deferred Tax Asset (Liability)	$	-		$	-

Assumptions_used_in_the_BlackS

Assumptions used in the Black-Scholes valuation model (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Assumptions used in the Black-Scholes valuation model	'	'
Risk-free interest rate	'0.10% - 1.75%	'0.37% - 1.18%
Expected life	'3 - 5 years	'1 month - 6 years
Expected volatility	'125% - 175%	'108% -171%
Dividends	0.00%	0.00%

Principal_assumptions_used_in_1

Principal assumptions used in applying the Black-Scholes model were as follows (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Principal assumptions used in applying the Black-Scholes model {2}	'	'
Risk-free interest rate	'0.10% - 1.75%	'0.36%
Expected life	'3 to 5 years	'3 years
Expected volatility	'125% - 175%	'117%
Dividends	0.00%	0.00%

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
GOING CONCERN DETAILS	'	'
Net Loss	($3,237,046)	($2,759,585)
Working capital deficit	5,600,000	4,600,000
Accumulated deficit	48,300,000	'
Issued notes payable	190,000	'
Convertible notes payable	301,000	'
Issued shares of common stock for the settlement	346,812,709	'
Accrued interest and fees	$24,850	'

PROPERTY_AND_EQUIPMENT_Details

PROPERTY AND EQUIPMENT (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
PROPERTY AND EQUIPMENT DETAILS	'	'
Leasehold improvement	$74,945	$74,945
Furniture and fixtures	31,987	49,265
Equipment	72,358	89,514
Property and equipment gross	179,290	213,724
Accumulated depreciation and amortization	-179,290	-164,710
Property and equipment, net	$0	$49,014

PATENTS_AND_TRADEMARKS_Details

PATENTS AND TRADEMARKS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
PATENTS AND TRADEMARKS DETAILS	'	'
Patents	$104,621	$97,164
Trademarks	2,720	2,720
Total cost	107,341	99,884
Accumulated amortization	-47,919	-41,816
Patents and trademarks, net	$59,422	$58,068

Estimate_for_amortization_expe

Estimate for amortization expense (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Estimate for amortization expense details	'
Estimate for amortization expense 2014	$6,100
Estimate for amortization expense 2015	6,100
Estimate for amortization expense 2016	6,100
Estimate for amortization expense 2017	6,100
Estimate for amortization expense 2018	6,100
Estimate for amortization expense 2019 and thereafter	28,922
Total Estimate for amortization expense	$59,422

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Inventories consist of the following	'	'
Raw materials	$0	$43,684
Finished Goods	141,636	279,034
Inventories	$141,636	$322,718

NET_LOSS_PER_SHARE_OF_COMMON_S2

NET LOSS PER SHARE OF COMMON STOCK (Details)	Dec. 31, 2013	Dec. 31, 2012
Conversion of preferred stock and convertible promissory	'	'
Warrants	176,574,286	85,652,403
Convertible promissory notes	492,877,340	187,297,345
Convertible preferred stock	1,545,760	1,545,760
Total	670,997,386	274,495,508

Liabilities_measured_at_fair_v

Liabilities measured at fair value on a recurring basis (Details) (USD $)	Quoted Prices in Active Markets for Identical Liabilities (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Balance at December 31,
			USD ($)	USD ($)
Balance, at Dec. 31, 2011	0	0	0	0
Embedded conversion feature	'	'	$224,000	$224,000
Warrant liability	'	'	39,300	39,300
Balance, at Dec. 31, 2012	0	0	263,300	263,300
Embedded conversion feature	'	'	206,500	206,500
Warrant liability	'	'	$92,500	$92,500
Balance, at Dec. 31, 2013	0	0	299,000	299,000

Summary_of_the_changes_in_fair

Summary of the changes in fair value using significant unobservable inputs (Details) (USD $)	Warrants	Conversion Feature	Total
Balance: at Dec. 31, 2011	446,400	68,800	515,200
Change in fair value of derivative liability	($537,500)	($460,800)	($998,300)
Included in liabilities (debt discount)	28,100	621,000	649,100
Included in stock based compensation	17,200	0	17,200
Included in stockholder's equity	85,100	-5,000	80,100
Balance: at Dec. 31, 2012	39,300	224,000	263,300
Change in fair value of derivative liability	-297,100	-95,900	-393,000
Included in liabilities (debt discount)	114,000	240,000	354,000
Included in stock based compensation	4,500	0	4,500
Included in liabilities (derivative expense)	209,800	35,400	245,200
Included in stockholder's equity	22,000	-197,000	-175,000
Transfers in and /or out of Level 3	$0	$0	$0
Balance: at Dec. 31, 2013	92,500	206,500	299,000

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Notes payable and accrued interest consist of the following	'	'
Notes payable and accrued interest (a)	'	$15,221
Notes payable and accrued interest (b)	75,000	75,000
Notes payable and accrued interest (c)	245,860	237,006
Notes payable and accrued interest (d)	175,841	165,628
Notes payable and accrued interest (e)	83,952	222,170
Notes payable and accrued interest (f)	0	'
Notes payable and accrued interest (g)	12,500	'
Notes payable and accrued interest	593,153	715,025
Less: Current maturities	-593,153	-706,829
Notes payable and accrued interest, net of Current maturities	'	$8,196

Recovered_Sheet1

Convertible promissory notes payable and accrued interest (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Convertible promissory notes payable and accrued interest:	'	'
Convertible notes payable	$1,449,619	$1,191,716
Discount on convertible notes	-210,781	-80,606
Convertible notes payable, net	1,238,838	1,111,110
Less current maturities	-1,238,838	-1,111,110
Long-Term Portion	$0	$0

CONVERTIBLE_NOTES_AND_NOTES_PA2

CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICER & DIRECTOR (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Convertible notes and notes payable - Officers & Director and accrued interest:	'	'
Convertible notes and notes payable - Officers & Director and accrued interest (a)	$435,382	$406,682
Convertible notes and notes payable - Officers & Director and accrued interest (b)	222,322	208,322
Convertible notes and notes payable - Officers & Director and accrued interest (c)	54,008	57,260
Convertible notes and notes payable - Officers & Director and accrued interest (d)	39,113	71,490
Convertible notes and notes payable - Officers & Director and accrued interest (e)	46,378	42,378
Convertible notes and notes payable - Officers & Director and accrued interest (f)	25,000	25,000
Convertible notes and notes payable - Officers & Director and accrued interest (g)	5,051	0
Total	827,254	811,132
Less: Current maturities	-827,254	-811,132
Convertible notes and notes payable - Officers & Director and accrued interest, net of Current maturities	$0	$0

Related_party_transactions_Det

Related party transactions (Details) (USD $)	Jul. 07, 2013	Jul. 01, 2013	Apr. 05, 2013	Mar. 31, 2013	Mar. 18, 2013	Jan. 02, 2013
Related party transactions Details	'	'	'	'	'	'
Company issued a total of warrants to purchase common stock to its officers and related parties	$650,000	$2,702,704	$3,846,152	$10,000,000	$15,000,000	$12,820,512
Company issued a total of warrants to purchase common stock to its officers for director fees	'	675,676	961,538	'	'	3,205,128
The Company recorded directors' annual compensation in connection with the issuance ofwarrants	'	50,000	50,000	'	'	50,000
The Company recorded expense of stock-based compensation in connection with the issuance of warrants	11,700	40,800	27,600	60,800	91,200	70,800
The Company recorded total expense of stock-based compensation in connection with the issuance ofwarrants	'	'	'	125,800	188,700	'
The Company recorded expense of stock-based compensation in connection with the issuance of common stock	'	'	'	65,000	97,500	'
Company issued a additional warrants to purchase common stock to its related parties	'	'	'	$10,000,000	$15,000,000	'

Commitments_and_contingencies_

Commitments and contingencies Operating Leases (Details) (USD $)	Jun. 01, 2014	Oct. 01, 2013	Mar. 24, 2013	Mar. 01, 2013	Mar. 01, 2012	24-May-10
Commitments and contingencies Operating Leases	'	'	'	'	'	'
Company recorded a charge for the loss on abandonment of property	'	'	'	'	$34,707	'
Company recorded an accrual expense on damages	'	'	'	475,930	475,930	'
Company recorded rent and rent related expenses	'	'	'	341,849	341,849	'
Company recorded rent and rent related expenses relating to the lawsuit.	'	'	'	229,234	229,234	'
Under the terms of the lease the Company paid a deposit of approximately	'	'	12,000	'	'	12,000
The minimum monthly lease payments due under this lease are approximately	$1,050	$3,500	$16,700	'	'	$16,700

PREFERRED_STOCK_Details

PREFERRED STOCK (Details)	Dec. 31, 2013	Dec. 31, 2012
Authorized Shares	'	'
Series A	400,000	400,000
Series B	51	51
Series D	2,000,000	2,000,000
Series F	1,000,000	1,000,000
Total	0	0
Outstanding Shares	'	'
Series A	52,500	52,500
Series B	0	51
Series D	93,000	93,000
Series F	38,644	38,644
Total	184,144	184,195
Par Value	'	'
Series A	52	52
Series B	0	0
Series D	93	93
Series F	39	39
Total	184	184
Current Annual Dividend Requirement	'	'
Series A	52,500	52,500
Series B	0	0
Series D	55,800	55,800
Series F	0	0
Total	108,300	108,300
Total Dividend Arrearage	'	'
Series A	990,100	937,600
Series B	0	0
Series D	975,600	919,800
Series F	190,328	190,328
Total	2,156,028	2,047,728
Dividend Arrearage Per Share	'	'
Series A	17.86	17.86
Series B	0	0
Series D	9.89	9.89
Series F	0	0
Total	0	0
Liquidation Preference (Including Dividend Arrearage)	'	'
Series A	1,515,100	1,462,600
Series B	0	0
Series D	1,510,350	1,454,550
Series F	0	0
Total	3,025,450	2,917,150

STOCK_WARRANTS_Details

STOCK WARRANTS (Details)	Dec. 31, 2013	Dec. 31, 2012
STOCK WARRANTS DETAILS	'	'
Issued warrants in connection with convertible promissory notes	32,283,332	1,933,333
Issued warrants in connection with various employment and compensation agreements	71,786,055	43,746,410
Issued warrants in connection with equity private placements	0	13,853,721
Warrants were exercised	10,707,030	0
Warrants expired	2,440,424	1,402,058

Warrant_Issuances_and_Warrant_

Warrant Issuances and Warrant Balances Outstanding (Details) (USD $)	Shares Underlying Warrants	Weighted Average Exercise Price	Intrinsic Value
Outstanding at Dec. 31, 2011	27,520,997	0.06	0
Granted	$59,533,464	$0.01	$0
Expired	-1,402,058	0.05	0
Exercised	0	0	0
Outstanding at Dec. 31, 2012	85,652,403	0.03	0
Granted	104,069,387	0.01	0
Expired	-2,440,474	0.09	0
Exercised	($10,707,030)	$0.01	$0
Outstanding at Dec. 31, 2013	176,574,286	0.02	0

COMPONENTS_OF_INCOME_TAXES_Det

COMPONENTS OF INCOME TAXES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Provision (benefit):	'	'
Current	$0	$0
Deferred	5,739,800	-1,009,700
Current	0	0
Deferred	961,500	-260,300
Change in valuation allowance	-6,701,300	1,270,000
Income tax provision (benefit)	$0	$0

Reconciliation_between_the_sta

Reconciliation between the statutory federal income tax rate (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Reconciliation between the statutory federal income tax rate:	'	'
U.S. Federal statutory rate	-34.00%	-34.00%
State tax benefit, net of federal tax	-5.70%	-5.70%
Sec 382 impairment of NOL carryover	2.58%	0.00%
Other permanent differences	1.80%	1.50%
Deferred tax true-up	-13.30%	-7.80%
Change in valuation allowance	-207.00%	46.00%
Income tax provision (Benefit)	0.00%	0.00%

Deferred_Tax_Asset_Details

Deferred Tax Asset (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Asset:	'	'
Net operating loss carryovers	$3,705,200	$10,939,700
Stock-based compensation	1,455,700	1,230,500
Derivative liability	82,000	32,000
Fixed asset depreciation	0	57,800
Contributions carryover	3,100	100
Accrued legal claims	173,000	0
Accrued compensation	503,100	309,100
Deferred rent	0	2,800
Total deferred tax asset	5,922,100	12,572,000
Valuation allowance	-5,838,700	-12,540,000
Net Deferred Tax Asset, net of valuation allowance	83,400	32,000
Convertible debt	-83,400	32,000
Total deferred tax liability	-83,400	32,000
Net Deferred Tax Asset (Liability)	$0	$0

SUBSCRIPTIONS_RECEIVABLE_Detai

SUBSCRIPTIONS RECEIVABLE (Details) (USD $)	Dec. 31, 2013
SUBSCRIPTIONS RECEIVABLE DETAILS	'
Company loaned the individual	$337,200
Note called for interest at a rate per annum	6.00%
Subscription receivable along with accrued interest was written off	$446,156

Subsequent_events_Issuance_of_

Subsequent events Issuance of Common Stock (Details) (USD $)	Sep. 15, 2014	Jul. 01, 2014	Jan. 08, 2014	Aug. 27, 2013	Jul. 09, 2013
Subsequent events Issuance of Common Stock	'	'	'	'	'
Company received proceeds of for the exercise of warrants	'	'	'	$10,500	$27,923
Company exercised number of warrants	'	'	'	1,093,750	2,389,817
Company issued shares of common stock to the warrant holder	'	'	'	9,545,455	27,202,727
Shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender	7,027,778	7,634,921	13,265,625	'	'
The Company recorded interest expense for issuance of penalty shares	$4,919	$12,979	$47,756	'	'

Subsequent_events_Issuance_of_1

Subsequent events Issuance of Promissory Notes (Details) (USD $)	Apr. 25, 2014	Feb. 20, 2014	Feb. 04, 2014	Jan. 23, 2014	Jan. 15, 2014
Subsequent events Issuance of Promissory Notes	'	'	'	'	'
Promissory Note was issued to a lender in the total amount	$100,000	$30,000	$15,000	$30,000	$15,000
The note matures on April 30, 2015 with the stated interest rate	8.00%	'	'	'	'

Subsequent_events_Issuance_of_2

Subsequent events Issuance of Convertible Promissory Notes (Details) (USD $)	Sep. 16, 2014	Aug. 13, 2014	Jul. 17, 2014	Jun. 19, 2014	Apr. 21, 2014	Apr. 04, 2014
Subsequent events Issuance of Convertible Promissory Notes	'	'	'	'	'	'
Company issued a convertible promissory note for to a related party	$23,000	$85,000	$23,000	$100,000	$2,500	$50,000
The note matures from the issuance date with the stated interest rate	10.00%	8.00%	10.00%	10.00%	0.00%	0.00%
The note is convertible into the Company's common stock at a discount of the lowest closing bid price	'	50.00%	50.00%	'	50.00%	40.00%
The note is convertible into the Company's common stock at a conversion price per share	$0.00	'	$0.00	$0.00	'	'
The warrants fully vested and have a life of 5 years from date of issuance are issued	9,200,000	'	4,600,000	10,526,316	'	'
Warrants were issued with an exercise price per share	$0.00	'	$0.00	$0.00	'	'
Company issued another convertible promissory note for to a related party	'	'	$20,000	'	'	'